SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 10-K

                            ANNUAL REPORT PURSUANT TO
                      SECTION 13 OR 15(d) OF THE SECURITIES
                              EXCHANGE ACT OF 1934
                   For the Fiscal Year Ended December 31, 1997

Commission File Number
       1-11768

                           RELIV' INTERNATIONAL, INC.
             (Exact name of Registrant as specified in its charter)

           Illinois                                     371172197
           --------                                     ---------
(State or other jurisdiction of                      (I.R.S. Employer
incorporation or organization)                     Identification Number)

 136 Chesterfield Industrial Boulevard
        Chesterfield, Missouri                             63006
 --------------------------------------                    -----
(Address of principal executive offices)                 (Zip Code)

                                 (314) 537-9715
                                 --------------
               Registrant's telephone number, including area code




Securities registered pursuant to Sections 12(b) and 12(g) of the Act:

                                                    Name of each exchange
    Title of Class                                  on which registered:
    --------------                                  --------------------
    Common Stock, without par value                 NASDAQ National Market tier 
                                                    of The NASDAQ Stock Market

         Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
Registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days. ___X___ Yes _______ No

         Indicate by check mark if disclosure of delinquent  filers  pursuant to
Item 405 of Regulation S-K is not contained  herein,  and will not be contained,
to the best of  Registrant's  knowledge,  in  definitive  proxy  or  information
statements  incorporated  in Part III of the Form 10-K or any  amendment  to the
Form 10-K. [ ]

         Based upon the closing price of $4.25 per share of Registrant's  Common
Stock as reported on NASDAQ  National  Market tier of The NASDAQ Stock Market at
February  25,  1998,  the  aggregate  market  value of the voting  stock held by
non-affiliates   of  the   Registrant   was  then   approximately   $25,248,000.
(Determination  of stock  ownership  by  non-affiliates  was made solely for the
purpose of responding to the  requirements of the Form and the Registrant is not
bound by this determination for any other purpose.)

         The number of shares outstanding of the Registrant's Common Stock as of
February 25, 1998, was 9,617,307 (excluding treasury shares).

                       DOCUMENTS INCORPORATED BY REFERENCE

         Portions of Registrant's Proxy Statement for the 1998 Annual Meeting of
Shareholders  to be filed  with  the  Commission  within  120 days of the end of
Registrant's last fiscal year is incorporated by reference into Part III.




PART I

Item No. 1 - Business
- ---------------------

General
- -------

         Reliv' International, Inc. (the "Company") was incorporated in Illinois
on February 11, 1985,  under the name American Life Investors,  Inc. The name of
the Company was changed to its  current  name on January 20,  1992.  The Company
maintains  its  principal  executive  offices  at  136  Chesterfield  Industrial
Boulevard, Chesterfield, Missouri 63006.

         The  Company  produces a line of food  products  including  nutritional
supplements,  diet management products, functional foods, a line of granola bars
and a sports  drink mix.  Functional  foods are  products  designed to influence
specific  functions of the body. The Company also  distributes a line of premium
skin care products.  These products are sold by subsidiaries of the Company to a
sales force of independent distributors who sell products directly to consumers.
The Company and its  subsidiaries  sell products to distributors  throughout the
United  States and in  Australia,  Canada,  New  Zealand,  Mexico and the United
Kingdom.

         The Company has two wholly-owned subsidiaries,  Reliv', Inc. ("Reliv'")
and  Reliv'  World  Corporation   ("Reliv'   World").   Reliv'  World  has  five
subsidiaries  - Reliv'  Australia,  Reliv'  Canada,  Reliv' New Zealand,  Reliv'
Mexico and Reliv' Europe.

         Reliv' was organized as an Illinois  corporation  on May 24, 1988, as a
wholly-owned subsidiary of the Company, and began selling nutritional supplement
products in October, 1988, in the United States.

         In Australia,  Canada, New Zealand,  Mexico and the United Kingdom, the
Company's products are sold through Reliv' World and its subsidiaries in each of
such countries.  Reliv' World was organized as an Illinois  corporation on March
30, 1992, as a wholly-owned  subsidiary of Reliv'. Reliv' World was organized to
conduct the foreign  sales  operations  of the Company and to own foreign  sales
operations and subsidiaries.  On July 1, 1992, Reliv' declared a dividend of all
of the  stock of  Reliv'  World and  distributed  all of such  stock to its sole
shareholder, the Company.

         In February,  1991,  Reliv' entered into a joint venture agreement with
an  Australian  corporation  and the joint  venture  began to  market,  sell and
distribute Reliv' products in Australia in May, 1991. Reliv' Australia Pty, Ltd.
("Reliv' Australia"), a wholly-owned subsidiary of Reliv' World, entered into an
agreement to purchase the joint venture interest of the Australian  corporation.
Reliv'  Australia also entered into an agreement with the three  shareholders of
the  Australian  corporation  under which a partnership  of such  persons,  as a
distributor of Reliv'  Australia,  is to receive,  for a period of 10 years from
March 1, 1992, 2 percent of sales in Australia  and New Zealand  (defined as the
designated  retail  selling  price of all  products,  on which  commissions  are
payable to distributors), up to approximately $10 million (AUS) in 1992, and $12
million (AUS) in all  subsequent  years during the term,  and 3 percent of sales





                                       2




that exceed those  figures.  Since March 1, 1992, the business of the Company in
Australia and sales of the Company's products there has been conducted by Reliv'
Australia.

         During April,  1992,  Reliv' New Zealand Limited ("Reliv' New Zealand")
was  organized  as a New Zealand  company and as a  wholly-owned  subsidiary  of
Reliv'  World  (except for nominal  shares held by an officer).  In June,  1992,
Reliv' New Zealand  began  selling the Company's  products  through  independent
distributors in New Zealand.

         On June 9, 1992, Reliv' Canada, Ltd. ("Reliv' Canada") was organized as
an Ontario, Canada corporation and as a wholly-owned subsidiary of Reliv' World.
Reliv' Canada commenced  operations during October,  1992, and began selling the
Company's products to distributors in Canada in November,  1992. On December 31,
1995, Reliv' Canada was converted to a Nova Scotia,  Canada unlimited  liability
company,  wholly-owned  by Reliv'  World  (except for one  percent  owned by the
Company), under the name Reliv' Canada Company.

         On June 28,  1993,  Reliv'  Mexico S.A. de C.V.  ("Reliv'  Mexico") was
organized as a Mexican  corporation  and as a wholly-owned  subsidiary of Reliv'
World  (except  for one share owned by the  Company).  Reliv'  Mexico  commenced
operations  in  June,  1993,  and  began  selling  the  Company's   products  to
distributors in Mexico in August,  1993. On December 20, 1994, Reliv' Mexico was
converted to a Mexican limited  liability  company under the name Reliv' Mexico,
S. de R.L. de C.V.

         On  July 1,  1995,  Reliv'  UK  began  the  marketing  and  sale of the
Company's  products in the United  Kingdom in accordance  with the Reliv' system
under a license and distributor  arrangement  with the Company.  Pursuant to the
terms of the  arrangement,  Reliv'  UK  purchased  all of its  requirements  for
products  from the Company and paid Reliv' World a royalty on products  sold. On
February 1, 1998, Reliv' Europe,  Inc., an Illinois corporation and wholly-owned
subsidiary of Reliv' World,  assumed ownership and control of the United Kingdom
operation,  and is  currently  negotiating  a formal  purchase  of all of Reliv'
U.K.'s capital stock.

Principal Products
- ------------------

         Through  its  subsidiaries,  the  Company  markets  and sells a line of
related products  including  nutritional  supplements,  weight control products,
functional foods, granola bars, sports drink mixes and a premium skin care line.

         The   nutritional   supplements   include   Reliv'  NOW(R)  and  Reliv'
Classic(R).  Both  products  are  designed  to  provide a  balanced  nutritional
supplement  for an  individual's  diet and  contain a variety  of  vitamins  and
minerals,  soy and other protein sources and various herbs.  The products are in
powdered  form to be mixed with  juice or other  beverages.  The Reliv'  Classic
formula has a U.S. patent and the Reliv' NOW formula is a no-yeast derivative of
the Reliv' Classic formula.  Reliv' NOW is available with all natural  flavoring
or in the original formula.




                                       3


         Reliv'  Ultrim-Plus(R) is designed as a meal replacement (for a maximum
of two meals per day) in a weight loss  program.  The product  incorporates  the
core  formulation  of Reliv' NOW,  including  vitamins,  minerals,  proteins and
herbs, as well as additional protein and nutrient sources. Reliv' Ultrim-Plus is
available  in three  flavors - vanilla,  chocolate  and  strawberry.  It is also
available in aspartame-free vanilla. The product is in powdered form for mixture
with water or milk.

         Reliv' Cellebrate(R) is a patented weight loss aid designed to suppress
appetite,  curb the storage of body fat, and  facilitate  the body's fat burning
process.  Reliv'  Cellebrate is in powdered form and is  recommended  to be used
alone or with Reliv' Ultrim Plus meal replacement.

         Reliv'  Celleboost(R)  is also a weight  loss aid  designed to suppress
appetite  and reduce  body fat.  Reliv'  Celleboost  is in  capsule  form and is
recommended to supplement Reliv'  Cellebrate,  Reliv'  Ultrim-Plus or to be used
alone. Reliv' Celleboost was introduced in January, 1996.

         Reliv' Ultra  Bar(R) is a line of granola bars  containing a mixture of
grains and nuts which use the core formulation of Reliv' NOW vitamins, minerals,
proteins and herbs.  Flavors include yogurt,  chocolate and raspberry carob. The
bars are a snack  food and  nutritional  supplement  and are  used  with  Reliv'
Ultrim-Plus as a meal replacement in a weight loss program.

         Reliv'  Innergize!(R) is a patented  powdered sports drink containing a
mixture of vitamins and minerals. Reliv' Innergize is available in lemon, orange
and cool punch flavors.

         Reliv'  Fibrestore(R) is a patented nutritional  supplement  containing
fiber, vitamins, minerals and herbs. The product is in powdered form for mixture
with water or juice.  A modified  version  of the Reliv'  Fibrestore  formula is
marketed  in Canada  under  the name  Herbal  Harmony  in  compliance  with that
country's nutritional regulations.

         Reliv'  Arthaffect(R)  is a nutritional  supplement and functional food
containing Arthred(TM), a patented form of hydrolyzed collagen protein, which is
clinically reported to nutritionally support healthy joint function. The product
is in powdered form for mixture with water, milk or juice. Reliv' Arthaffect was
introduced in October, 1996.

         Reliv'  Getabetterbody(TM)  Weight  Loss System is a weight loss system
kit  containing  Reliv' Ultrim Plus,  Reliv'  Cellebrate  and Reliv'  Celleboost
together  with product  information  and other tools to be used in a weight loss
program.

         Reliv'  ProVantage(TM)  is a  nutritional  supplement  containing  soy,
designed  to enhance  athletic  performance.  The  product is also of benefit to
dieters  and others  wanting to  increase  their soy  intake.  The product is in
powdered form for mixture with water or juice.  Reliv' ProVantage was introduced
in October, 1997.

         In May, 1997, the Company  introduced Reliv' Healthy Pantry(TM) premium
entrees,  a line of soy-based  functional foods. The meals are designed to offer
the advantages of soy in low fat, easy to prepare meals. The line includes Pasta
Prima Vera,  Hearty Chili,  Hearty Burger and Ala King dinner.  The meals are in
dried form and can be prepared quickly with a minimum of additional ingredients.




                                       4



         The Company also markets a line of skin care products which is based on
compounds  found only in the  avocado.  The  products  are  designed  to be used
individually or in combination with each other.  The product line includes:  (i)
Reliv' Face and Body Bar, a mild face and body soap; (ii) Reliv'  Pathway(R),  a
skin cleanser and primer which contains a variety of avocado based  ingredients;
(iii) Reliv'  Reavo(R),  a skin care cream  designed to reduce the appearance of
aging in the skin caused by natural and  environmental  causes;  and (iv) Reliv'
R.P. 1.5(R), a skin care cream having the active ingredient retinyl palmitate is
designed to reduce the appearance of aging caused by  environmental  causes such
as exposure  to the sun.  The  Company's  skin care line also  includes  toners,
moisturizers, sunless tanning lotions and related items.

         The Company  conducts  ongoing  research and development on its product
line and intends to  introduce  additional  product  items.  See  "Research  and
Development."


Patents and Trademarks
- ----------------------

         The Company has obtained  U.S.  patents on the  formulations  of Reliv'
Innergize!, Reliv' Fibrestore and Reliv' Cellebrate.

         The Reliv'  Classic  formula has a U.S.  Patent.  Reliv' NOW is a trade
secret formulation which is a derivative of the Reliv' Classic formulation.  The
core mixture of Reliv' NOW is incorporated in Reliv'  Ultrim-Plus and the Reliv'
Ultra Bars.  These  products are  manufactured  and sold by the Company under an
Exclusive  License Agreement dated December 1, 1991 ("License  Agreement").  The
License  Agreement is worldwide in scope and  continues  through the life of the
patent.  Pursuant to the License Agreement,  the Company is obligated to pay the
owner of the patent and the  developer  of the  formulations,  Dr.  Theodore  P.
Kalogris,  a royalty  of 5 percent  of the  revenues  from the sale of  products
containing the licensed  formulas,  with a minimum  $10,000 and maximum  $22,000
monthly  royalty.  The  Company's  obligation  to pay the royalty  payments will
terminate on the later of (i) 10 years from the date of the License Agreement or
(ii) the death of Dr. Kalogris,  and the License  Agreement will be deemed to be
paid in full at that time.

         The  principal  ingredient  of Reliv'  Arthaffect  is the subject of an
issued U.S. patent.  Under an agreement dated November 6, 1996, Traco Labs, Inc.
("Traco"),  exclusive  licensee of the patent rights,  sublicensed the rights to
sell the product to the Company  ("Traco  Agreement").  The license is exclusive
for direct sales in certain  sales areas and is for a term ending upon the later
of (i) the  termination of Traco's rights to market the product or (ii) December
31,  2014.  The Traco  Agreement  provides  that the Company  will  purchase its
requirements  of the product from Traco,  and the  exclusivity of the license is
contingent on minimum purchases of the product being made by the Company.






                                       5



         The  principal  ingredient  of Reliv' Reavo is the subject of an issued
U.S. patent. On July 1, 1995, Avogen,  Inc.  ("Avogen") granted to the Company a
license under such patent and other proprietary rights relating to the skin care
line of products,  to purchase such products from or through  Avogen and to sell
and  distribute  the products (the "Avogen  Agreement").  On April 25, 1997, the
Avogen  Agreement  was amended.  The Avogen  Agreement is worldwide in scope and
continues  through the later of the last to expire of the patents subject to the
Avogen  Agreement  or December 31, 2014.  Pursuant to the Avogen  Agreement,  as
amended, the Company was granted an exclusive license to market its current line
of skin care products  subject to the Agreement,  and is obligated to pay Avogen
royalties which vary depending on the product sold.

         Trademark  registrations for "Reliv'" and for the many of the Company's
product  names are either  issued or pending  in the U.S.  Patent and  Trademark
Office.  Trademark  registrations for selected marks have been issued or applied
for in Australia,  New Zealand,  Canada,  Mexico, the United Kingdom and several
other foreign countries.  The Company considers its trademarks and tradenames to
be an important asset of its business.


Sales and Marketing
- -------------------

         The Company sells its products to a network of independent contractors,
designated  as  "distributors",  who in  turn  sell  the  products  directly  to
consumers.  The Company's  products are marketed and sold to distributors in the
United States,  Australia,  Canada,  New Zealand,  Mexico and the United Kingdom
through a subsidiary in each country.  The marketing  efforts of the Company and
these subsidiaries are focused on the development,  training and support of this
network of independent  distributors.  The Company,  through these subsidiaries,
supports  an  active  training   program  for   distributors  in  which  Company
representatives and experienced  distributors lead group training sessions.  The
Company  and these  subsidiaries  also  create  and  provide  distributors  with
manuals,   brochures   and  other   promotional,   training  and   informational
publications.  Periodically,  each subsidiary sponsors  distributor  meetings at
which Company  representatives  provide training and information  concerning the
Company's products. Company subsidiaries also sponsor group telephone conference
calls for training and promotional activities.

         Distributors  consist  principally of  individuals,  although a limited
number of distributors are  corporations or  partnerships.  New distributors are
sponsored by existing distributors.  A new distributor is required to complete a
distributor application and, in most areas, to purchase a package of distributor
materials (for $39.95 in the United States) consisting of a distributor  manual,
business forms and promotional  materials.  Distributors  purchase products from
Company subsidiaries or from other distributors for resale or consumption by the
distributor or his or her family.

         In each country in which the Company  conducts  business,  distributors
operate under a uniform  distributor  system which  compensates  distributors at
varying levels based on sales volumes.  Initially, a distributor is designated a
Retail  Distributor  and  is  entitled  to  purchase  products  from  a  Company
subsidiary or other  distributors at a discount of 25 percent from the Company's
suggested retail price. A distributor is promoted to higher levels in the system
by increasing  his or her sales of the Company's  products,  directly or through
other distributors  sponsored in the distributor's sales group, and by achieving
designated  sales volumes.  These higher ranks of distributor  are designated in
order as Affiliate,  Key Affiliate,  Senior Affiliate and Master  Affiliate.  At
each  higher  level,  a  distributor  is  entitled  to  purchase  products at an
increasingly higher discount; a Master Affiliate receives a 45 percent discount.





                                       6




         Distributors receive retail profits equal to the difference between the
price at which they sell the product to customers and the discounted  price they
paid for the product.  Distributors also earn wholesale  commissions on products
purchased by other  distributors in the  distributor's  sponsored group equal to
the  difference  between  the  price at which the  distributor  is  entitled  to
purchase  product  at and the  price at  which  downline  distributors  purchase
product.  The Company  pays a Master  Affiliate  a  commission  with  respect to
products purchased directly from the Company by Retail Distributors, Affiliates,
Key  Affiliates or Senior  Affiliates  directly  sponsored by them or who are in
their  personally  sponsored  group (i.e.,  individuals  sponsored by the Master
Affiliate's  distributors,  directly or indirectly).  The commission is equal to
the difference  between the prices at which such  distributors  were entitled to
purchase  products  and the 45  percent  discounted  price  available  to Master
Affiliates.  Senior  Affiliates,  Key  Affiliates and Affiliates are entitled to
receive  from their  Master  Affiliate a portion of the  commission  paid to the
Master Affiliate, based upon the purchases of products from Company subsidiaries
by distributors sponsored by them or by distributors in their personal group.

         Master Affiliates are also entitled to receive additional  compensation
payments of two percent to five  percent of the retail  sales  volume of product
purchased from Company  subsidiaries  by Master  Affiliates  (and their personal
groups) whom they have sponsored,  and for up to five levels of sponsorship.  To
qualify  for these  additional  compensation  payments,  Master  Affiliates  are
required to maintain certain monthly sales volumes and document specified levels
of retail sales.  Master Affiliates who sponsor other  distributors to the level
of Master  Affiliate  are entitled to become part of the Director  Program,  and
attain  higher  positions in the program  based on the size of their  additional
compensation  payments.  The levels of Director,  in order,  are  Director,  Key
Director,   Senior  Director,   Master  Director  and   Presidential   Director.
Distributors  reaching these levels receive pins and/or rings  recognizing their
achievement and  recognition in Company  publications  and at Company  sponsored
activities.

         In mid-1996,  the Company  introduced the Star Director Program,  which
allows Directors to receive increased additional  compensation payments based on
the number of Master Affiliates they have sponsored since the program commenced.
Directors are entitled to receive an additional  one percent to three percent of
additional compensation on the retail sales volume of Master Affiliates in their
sponsorship.

         The Company  also  sponsors  an  Ambassador  Program.  To qualify as an
Ambassador a distributor  must hold the level of Master Director and must assist
personally sponsored Master Affiliates in meeting specified levels of additional
compensation  payments.  The levels of  Ambassador  are,  in order,  Ambassador,
Bronze Ambassador,  Silver Ambassador,  Gold Ambassador and Platinum Ambassador.







                                       7



As higher levels are reached,  Ambassadors are entitled to increased percentages
of the retail sales volume of Master  Affiliates  below them through five levels
of sponsorship,  and at the two highest levels,  a percentage of the sixth level
of sponsorship below their personally  sponsored Master Affiliates.  Ambassadors
are also  entitled,  depending on the level,  to  additional  benefits,  such as
participation  in Company  sponsored  events,  paid hotel rooms at  conventions,
health  insurance  and car  allowances.  Once a  month,  a group  of high  level
Ambassadors meet with Company executives in the "Reliv Inner Circle" to exchange
ideas on new programs, products and marketing opportunities.

         The Company's Direct Selectsm program is available in the United States
whereby  distributors  and their retail customers may order product in less than
case lots  directly  from the Company by phone.  An  automatic  monthly  reorder
program is also  available.  Product is shipped  directly  to the  customer  and
distributors earn a commission on Direct Select sales made to their customers.

         Company subsidiaries also provide a variety of additional incentives or
bonuses to the most productive distributors.

         As of December 31, 1997,  37,826 persons or entities were registered as
distributors of Company subsidiaries of which 4,374 were Master Affiliates. This
is an increase  from March,  1997 totals of 36,465  distributors  of which 3,325
were  Master  Affiliates.  The  number of  registered  distributors  and  Master
Affiliates in each country in which Company subsidiaries operate is as follows:

                                            
                                                                Master
                                       Distributors           Affiliates
                                       ------------           ----------
          
          United States                     29,616                3,631

          Australia                          3,118                  221
          
          New Zealand                        1,083                   83
                
          Canada                             2,130                  244

          Mexico                               867                  158

          United Kingdom                     1,012                   37


     Not all persons  registered as  distributors  of Company  subsidiaries  are
active.  Reliv' requires that persons wishing to continue as distributors  renew
their  distributorship  annually  by the  payment  of a fee  ($20 in the  United
States);  the  number of  distributors  shown in the  preceding  table  reflects
persons  who have  become  distributors  within the past 12 months and those who
renewed their distributorship during 1997.







                                       8



         The  Company  recognizes  that  its  sales  growth  is  based  upon the
continued  development  of its  independent  distributor  force and  strives  to
maintain an active and motivated  distributor  network  through a combination of
quality products,  discounts,  commissions and bonus payments, sales conventions
and training, personal recognition and a variety of publications and promotional
materials.

         The  Company  recognizes  that  businesses  in  the  network  marketing
industry risk the possibility  that a portion of sales made to distributors  may
not be consumed or sold to consumers and instead, may remain as inventory in the
distributors'   possession.   The   Company's   distributor   organization   and
compensation  system  is  designed  and  intended  to  promote  the  sale of the
Company's products to consumers by distributors.  Sales training and promotional
efforts  emphasize that  intention.  To that end, and to comply with  applicable
governmental  regulations of multilevel selling  organizations,  the Company and
each  subsidiary  have  established   specific  programs  and  requirements  for
distributors   including   (i)   monitoring  by  the  Company  of  purchases  by
distributors  to  identify  potentially  excessive  individual  purchases,  (ii)
requiring  that  distributors  certify to a specified  amount of retail sales to
receive  commissions,  and (iii) requiring that distributors certify the sale of
at least 70 percent of previous  purchases  prior to the purchase of  additional
amounts of product.  The Direct  Select  program,  as described  above,  further
promotes  sales of the  Company's  products to consumers.  Distributors  are not
required  at any  time to  purchase  product,  although  Master  Affiliates  are
required to maintain  certain  minimum sales levels in their personal  groups to
continue receiving royalty compensation payments.

         Each subsidiary  maintains a policy that unused product may be returned
by customers to the selling distributor or the subsidiary or licensee for a full
refund within 30 days after  purchase.  Each  subsidiary also maintains a policy
that any distributor  who terminates his  distributorship  may return  resalable
product for a refund of 90 percent of the purchase  price less any  discounts or
commissions received relating to the purchase of the products.

         The Company has  established  a suggested  retail price for each of the
Company's products in each country in which the Company conducts  business,  but
distributors  are  free to  determine  the  price at which  they  will  sell the
Company's products.  Distributors are not assigned  territories and there are no
restrictions on marketing areas for distributors.

         In the United States, the Company's products are warehoused and shipped
by common carrier to distributors.  A facility in Chesterfield,  Missouri serves
the east and central  parts of the  country  and the  Company  utilizes a public
warehouse facility in Las Vegas,  Nevada to supply the West Coast. See "Item No.
2 -  Properties".  Products  are  also  warehoused  in,  and  shipped  to  local
distributors from: Sydney,  Australia;  Auckland, New Zealand;  Toronto, Canada;
Mexico  City,  Mexico;  and  London,  England.  Each  subsidiary  of the Company
maintains  an office and  personnel  to  receive,  record and fill  orders  from
distributors.  Distributors order product from Company subsidiaries in case lots
and pay for the goods prior to shipment. In general, state or local governmental
sales taxes are collected by Company subsidiaries for taxing authorities.






                                       9



Manufacturing and Product Sources
- ---------------------------------

         The  Company  established  a  manufacturing  line  at its  facility  in
Chesterfield,  Missouri and had begun manufacture of its nutritional products in
early 1993. Shortly after manufacturing  commenced,  the facility was flooded in
July 1993, as a result of a break in a levee on the Missouri River.  The Company
initiated the return of manufacturing  to its Chesterfield  facility in mid-1995
and currently  manufactures  all of its products  (except  granola bars and skin
care products) at this facility.  The Company expanded its Chesterfield facility
in 1997. See "Item No. 2 - Properties".

         In 1996, the Company received approval from the Australian  Therapeutic
Goods  Authority  ("TGA")  to  manufacture  products  sold in  Australia  at its
Chesterfield  plant.  The  Company  is in the  process  of  reducing  its use of
contract  manufacturers  in Australia and intends to manufacture the majority of
Australia's  requirements of nutritional products at its Chesterfield  facility.
The certification of the Company's Chesterfield site by the Australian TGA, also
satisfied  Canadian  manufacturing  requirements  and the  Company  manufactures
substantially  all of the nutritional  products sold in Canada.  The Company has
not  experienced  any difficulty in obtaining  supplies of raw materials for its
nutritional  products and does not believe it will encounter any such difficulty
in the future.

         The Company's granola bars are manufactured by contract manufacturers,
predominantly  located  in the  United  States,  who  produce  the  products  in
accordance  with formulas  provided by the Company,  subject to quality  control
requirements and inspections by representatives of the Company. During 1997, the
Company's  line of skin care  products was supplied to it pursuant to the Avogen
Agreement  and was  purchased  from Avogen and various  contract  manufacturers.
Arthred(TM),  the principal ingredient of Reliv' Arthaffect,  is supplied to the
Company by Traco.  The  Company  has had no  difficulty  in  obtaining  contract
manufacturing  and there has been no  material  effect on the  timely  supply of
goods.


Research and Development
- ------------------------

         At its Chesterfield  facility,  the Company conducts research,  product
development and formulation,  testing and quality control,  all relating to food
products. Research and development costs were $286,000 in 1997, $289,000 in 1996
and $294,000 in 1995.


Employees
- ---------

         As  of  December  31,  1997,  the  Company  and  all  subsidiaries  had
approximately  162 full-time  employees  compared with 202 such employees at the
end of 1996. This resulted from an increase in sales, marketing and distribution
personnel  to  support  increased  network  maketing  sales  and a  decrease  in
manufacturing and warehouse  employees as a result of a decrease in the contract
manufacturing  business segment. The Company believes that its relationship with
its employees is satisfactory.  In June of 1996, the Company's manufacturing and
warehouse employees  certified  representation by the local Teamsters Union. The
Union  and  the  Company  are  currently  negotiating  a  collective  bargaining
agreement.







                                       10


Product Regulation
- ------------------

         The formulation, labeling and advertising or promotion of the Company's
products are subject to regulation  by the Federal Food and Drug  Administration
(FDA) which  regulates the Company's  products under the Federal Food,  Drug and
Cosmetic  Act (the  "FDCA"),  the  Federal  Trade  Commission  (FTC) and various
agencies  of the states or  countries  into  which the  Company's  products  are
shipped or sold. FDA  regulations  include  requirements  and  limitations  with
respect to the labeling of the Company's  food products and also with respect to
the  formulation of those  products.  The skin care products sold by the Company
are also subject to FDA regulations with respect to formulation and marketing of
cosmetics.  FDA regulations also limit and control the extent to which health or
other  claims can be made with  respect to the efficacy of any food or cosmetic.
The FDCA has been amended several times with respect to nutritional supplements,
most recently by the  Nutrition  Labeling and Education Act of 1990 (the "NLEA")
and the Dietary  Supplement  Health and  Education Act of 1994 (the "DSHEA") and
related  regulations.  Such  legislation  governs  the  marketing  and  sale  of
nutritional  supplements,  including  the  content  and  presentation  of health
related   information   included  on  the  labels  or  labeling  of  nutritional
supplements.  The Company does not believe these laws or regulations will have a
material  effect  on  its  products  or  operations.   Nutritional  and  dietary
supplements  such as those  manufactured  and sold by the Company,  for which no
therapeutic  claim is made, are not subject to FDA approval prior to their sale.
The Company  presently  does not  anticipate  marketing new products which would
require FDA approval.  However, these products can be removed from the market if
shown  to be  unsafe,  and if the  FDA  determines,  based  on the  labeling  of
products,  that the  intended  use of the  product is for the  diagnosis,  cure,
mitigation treatment or prevention of disease, it can regulate those products as
drugs and require pre-market clearance.  In addition, if the FDA determines that
the claims  concerning a product's  affect on the "structure or function" of the
body do not meet the  requirements  of DSHEA,  such claims  could result in such
product being subject to regulation as a drug.

         The Company's  advertising of its  nutritional  supplement  products is
also subject to regulation by the FTC under the Federal  Trade  Commission  Act,
which  prohibits  unfair  or  deceptive  trade  practices,  including  false  or
misleading advertising.  The FTC in recent years has brought a number of actions
challenging  claims by  companies  (other than the  Company) for weight loss and
"fat burning" dietary supplement products and plans.

         Governmental  regulations in foreign  countries where the Company plans
to  commence  or expand  sales may  prevent  or delay  entry  into the market or
prevent or delay the introduction,  or require the reformulation,  of certain of
the Company's  products.  Such  regulations  have caused  delays in  introducing
certain of the Company's  products in the past and such delays have had negative
affects on sales.

         The  Company  may  be  subject  to  additional   laws  or   regulations
administered  by  the  FDA  or  other  federal,   state  or  foreign  regulatory
authorities,  the  repeal of laws or  regulations  which the  Company  considers
favorable,  such as the DSHEA, or more stringent interpretations of current laws
or  regulations,  from  time to time in the  future.  The  Company  is unable to
predict  the  nature  of  such  future  laws,  regulations,  interpretations  or
applications, nor can it predict what effect additional governmental regulations
or administrative orders, when and if promulgated, would have on its business in
the future.






                                       11




Sales Program Regulation
- ------------------------

         The Company's  distribution  and sales program is subject to regulation
by the FTC and  other  federal  and state  regulation.  Various  state  agencies
regulate  multi-level  distribution  activities.  The  Company  is  required  to
register  with,  and submit  information  to,  certain of such  agencies and has
complied fully. The Company actively strives to comply with all applicable state
and  federal  laws and  regulations  affecting  its  products  and its sales and
distribution  programs.  The Attorney  Generals of several  states have taken an
active role in investigating and prosecuting  companies whose compensation plans
they feel violate local anti-pyramid  and/or consumer protection  statutes.  The
Company is unable to predict the effect such increased activity will have on its
business in the future nor is the Company  able to predict  the  probability  of
future  laws,  regulations  or  interpretations  which may be passed by state or
federal regulatory authorities.

         Under current law, the Company's  distributors  are treated for federal
income tax purposes as independent  contractors and compensation paid to them is
not subject to withholding by the Company. Several bills have been introduced in
Congress  which would  restrict the  definition of  independent  contractor  and
possibly  jeopardize the exempt status enjoyed by direct sellers.  Such a change
would negatively  impact the Company's  recruiting  efforts.  The direct selling
industry is strongly  opposing such bills as they relate to direct sellers.  The
Company  is unable to assess the  likelihood  of these or  similar  bills  being
enacted.  In several states,  legislation has been introduced which would narrow
the definition of independent  contractor for purposes of income tax withholding
as well as unemployment  compensation,  worker's compensation and other employee
benefits.  To date, the status of direct sellers as independent  contractors has
not been  affected.  States  are  becoming  increasingly  active  in this  area,
however,  and there is no assurance  that future  legislation at the state level
affecting direct sellers will not be enacted.


Competition
- -----------

         The Company's products are sold in highly  competitive  markets against
companies with substantially  greater sales volume and financial  resources than
the Company and with brands that are,  through  advertising  and other  methods,
better known to consumers.  The Company  competes  against other direct  selling
companies  and against  companies  which sell  heavily  advertised  and promoted
products through retail stores,  including supermarkets,  drug stores and health
food stores. The Reliv' Ultrim-Plus,  Cellebrate and Celleboost products compete
with numerous  other  products in the weight loss market,  including  nationally
advertised  products such as SlimFast(tm).  Many companies have entered, or have
plans to  enter,  the  sports  drink  market  in  which  Reliv'  Innergize!  and
ProVantage compete, a market long dominated by Gatorade(tm).  Reliv' NOW, Reliv'
Classic  and  Reliv'  Fibrestore  compete  with  numerous  mineral  and  vitamin
supplement products. The Company's skin care line competes with products sold by
numerous,  well-established cosmetic companies, including several direct selling
companies such as Mary Kay and Avon.  With  Arthaffect,  the Company has entered
the relatively new "functional foods" market,  which is expected to be extremely
competitive and led by the major food companies.






                                       12


International Operations
- ------------------------

         Prior to 1991, the Company marketed and sold its products solely within
the United States.  In February,  1991, Reliv' entered into a joint venture with
an Australian  corporation and the joint venture began marketing and selling the
Company's  products in Australia in May,  1991. As of March,  1992,  the Company
organized  Reliv'  World  to  conduct  international  operations,  acquired  the
business  of the  Australian  joint  venture  and began  conducting  business in
Australia through Reliv'  Australia.  In June, 1992, the Company began marketing
and selling its products in New Zealand through Reliv' New Zealand, in November,
1992,  began marketing and selling its products in Canada through Reliv' Canada,
and in August,  1993, began marketing and selling its products in Mexico through
Reliv'  Mexico.  In July,  1995,  the Company  began  marketing  and selling its
products in the United Kingdom through Reliv' UK, a licensee. In February, 1998,
Reliv' Europe assumed the operations of Reliv' U.K.

         Each foreign subsidiary markets,  sells and uses substantially the same
line of products,  labeling and method of  distribution  as Reliv' in the United
States, although not all of the Company's products are available in each country
and  the  formulation  of  some  of the  products  vary  to  comply  with  local
governmental regulations or requirements.

         Reference is made to Note 18 of the Consolidated  Financial  Statements
contained in Part IV hereof for financial information on geographical segments.


Contract Manufacturing
- ----------------------

         In the last quarter of 1995, the Company commenced  providing  contract
processing and packaging  services at its Chesterfield  manufacturing  facility.
These  services  include  blending,  processing  and packaging  food products in
accordance with  specifications or materials provided by the customer.  Revenues
from these services during 1996 were $3,310,000,  but decreased to $1,525,000 in
1997,  as a result of the loss of a major  customer.  The  Company  is  actively
seeking additional contract manufacturing business.

         Reference is made to Note 17 of the Consolidated  Financial  Statements
contained in Part IV hereof for financial information on business segments.


Item No. 2 - Properties
- -----------------------

         The  Company  owns  approximately  six  acres  of land  and a  building
containing  approximately  136,000  square  feet of  office,  manufacturing  and
warehouse space located at 136 Chesterfield Industrial Boulevard,  Chesterfield,
Missouri,  63006, where it currently maintains its corporate  headquarters.  The
Company  recently  completed an expansion to the  Chesterfield  facility on land
owned by the Company adjacent to existing building.  Approximately 90,000 square
feet of  manufacturing,  warehouse  and office  space was added to the  existing
46,000  square  foot  facility.  The  Company  obtained a  construction  loan of
$4,430,000 to finance the expansion.

     The original  property was  purchased  in July,  1991,  and, as part of the
purchase  price for the premises,  the Company  assumed the remaining  principal
balance of $850,108 of a 1984 industrial revenue bond with an original principal
sum of $975,000.  In  addition,  the Company  executed a promissory  note to the
seller  in the  amount  of  $250,000.  The  principal  balances  of the bond and





                                       13



promissory  note at December 31, 1997, are $598,000 and $205,000,  respectively.
The promissory  note is secured by a deed of trust on the premises.  The Company
intends to fund its payments  under the  industrial  revenue bond and promissory
note from working  capital.  In 1992,  the Company  completed an addition to its
building  of  approximately  12,000  square feet used for  manufacturing  of its
products.  In May, 1993, the Company purchased 3.4 acres of land adjacent to the
original facility for $400,000.

         The main facility and surrounding  land was severely damaged by a flood
in July,  1993. The Company began repairs and improvements to its main facility,
and finalized  relocation of its corporate  offices to the facility in February,
1995. The Company's  decision to return to the facility was based on its ability
to obtain  adequate flood  insurance to offset future losses if incurred and the
government's direction toward upgrading the levee that protects the facility.

         During 1997,  the Company  leased  approximately  20,800 square feet of
warehouse space at a separate site in Chesterfield,  Missouri,  at a rental rate
of $8,700  per  month,  for  shipping  and  finished  goods  storage.  The lease
terminated  in  December,  1997,  and the  Company  anticipates  that its  newly
expanded  facility  will meet its local  shipping  and  warehouse  needs for the
foreseeable future.

         The Company leases office space in Parramatta,  Australia, Mississauga,
Ontario,  Canada and in Mexico City,  Mexico to support its  operations in those
areas, and has a contract warehouse arrangement in Auckland, New Zealand.


Item No. 3 - Legal Proceedings
- ------------------------------

         On May 21, 1997,  Timothy Tobin,  a former  director and officer of the
Company,   filed  a  Demand  for  Arbitration  with  the  American   Arbitration
Association in St. Louis,  Missouri.  The Demand claimed damages  resulting from
alleged  misrepresentations  made  by the  Company  in  connection  with a Stock
Purchase  Agreement  and  Consulting  Agreement  entered  into with Mr. Tobin in
October  1992.  The  Company  has filed an Answer and  Counterclaim  denying Mr.
Tobin's  allegations and claiming  damages  resulting from Mr. Tobin's breach of
warranties contained in the October 1992 agreements.


Item No. 4 - Submission of Matters to a Vote of Security Holders
- ----------------------------------------------------------------

N/A




                                       14


PART II

Item No. 5 - Market  for  Registrant's  Common  Equity and  Related  Stockholder
- --------------------------------------------------------------------------------
Matters
- -------

         The  Company's  Common  Stock was  admitted to trading on the  Emerging
Company  Market  Place at the  American  Stock  Exchange  on  March 8,  1993 and
subsequently was approved for listing on the American Stock Exchange Main Board.
Prior to that  time,  there was no  established  public  trading  market for the
Company's  Common Stock.  On September 6, 1996, the Company moved the listing of
its Common Stock to the NASDAQ  National  Market Tier of the NASDAQ Stock Market
under the symbol: RELV.

                         1997 and 1996 Quarterly Stock Price Data
                         ----------------------------------------


                                   HI             LO
                                   --             --
                                                     
1997
- ----
First Quarter                      7.625          5.341 
Second Quarter                     8.625          6.00                       
Third Quarter                      7.00           5.25                    
Fourth Quarter                     5.75           2.75  
                
                                                        
1996                                                    
- ----                                                    
First Quarter                      2.273          1.477
Second Quarter                     3.864          1.818
Third Quarter                      7.727          2.727
Fourth Quarter                    11.136          5.227
                                          
          
         All 1996  stock  price  data has been  retroactively  adjusted  for the
Company's 10% stock dividend issued in February 1997.

         As of February  25, 1998,  there were  approximately  1,641  holders of
record of the Company's Common Stock.

         On May 15, 1996, a dividend of $.005 per share was paid to shareholders
of  record.  On  December  6, 1996,  a  dividend  of $.015 per share was paid to
shareholders  of record.  On February 28, 1997, a 10% stock  dividend and a cash
dividend of $.01 per share was paid to shareholders of record. The cash dividend
on such date was paid on all shares after giving  effect to the stock  dividend.
On June 13, 1997, a cash dividend of $.02 per share was paid to  shareholders of
record.  On January  29,  1998,  a cash  dividend  of $.01 per share was paid to
shareholders  of  record.  The amount  and  timing of future  dividends  will be
subject to  declaration  of the Board of  Directors  consistent  with results of
operation of the Company and its financial condition at the time.

         In  March,   1995,  the  Company   instituted  an  automatic   dividend
reinvestment  plan for its  shareholders of record.  Participation  in the plan,
which is voluntary,  provides for dividends paid by the Company to be reinvested
in shares of common stock at the then current market price. The plan also allows
participants  to make  additional  voluntary  purchases  of  common  stock  on a
quarterly basis at the market price.





                                       15



Item No. 6 - Selected Financial Data

     The following  selected  financial  data are derived from the  consolidated
financial statements of the Company. The data should be read in conjunction with
the  consolidated  financial  statements,  related  notes,  and other  financial
information included herein.




                                                                      Year ended December 31
                                                    1997           1996         1995         1994          1993    
                                                 -----------------------------------------------------------------
                                                                                                           (1)
                                                                                                   
Net Sales                                        $46,836,270    $40,729,993  $28,913,873  $32,190,444  $43,553,022   
                                                                
Income from continuing operations, before                       
extraordinary loss                               $ 2,028,988    $ 1,507,014  $   569,823  $   893,766  $ 3,062,398   
                                                                
Net Income                                       $ 2,028,988    $ 1,507,014  $   569,823  $   893,766  $ 1,649,398   
                                                                
Earnings (loss) per common share(2):

Basic:

Income before extraordinary loss                      .21            .15          .06          .09          .29  
                                                             
Extraordinary loss                                    ---             --          ---          ---         (.13) 
                                                 -----------------------------------------------------------------
     Net Income                                       .21            .15          .06          .09          .16  
                                                             
Diluted:                                               
                                                             
Income before extraordinary loss                      .20            .15          .06          .09          .29  
                                                             
Extraordinary loss                                    ---            ---          ---          ---         (.14) 
                                                 ----------------------------------------------------------------
     Net Income                                       .20            .15          .06          .09          .15  
                                                             
Cash Dividends per share of Common Stock              .03            .02          .01         .015           --  
                                                             
Total Assets                                     $15,969,948    $11,401,665  $10,276,234  $ 9,660,013  $10,525,380  
                                                             
Long-term debt and capital lease obligations,                
less current maturities                          $ 5,148,625    $ 1,478,079  $ 1,416,764  $ 1,000,024  $ 1,072,070  
                                                             
                                         

(1)     In July, 1993,  during the Midwestern  floods, a levee broke and flooded
        300  area   businesses,   including  the  Company's   headquarters   and
        manufacturing  facility.  The effects of this event have been  accounted
        for as an extraordinary loss.

(2)     All earnings per share data has been retroactively  adjusted for the pro
        forma  effect of the  Company's  10% stock  dividend  issued in February
        1997.





                                       16


Item No. 7 -  Management's  Discussion  and Analysis of Financial  Condition and
- --------------------------------------------------------------------------------
Results of Operations
- ---------------------

Results of Operations
- ---------------------

Net Income

1997 vs. 1996

         The  Company's  1997 net income was  $2,029,000 or $.21 per share ($.20
per share  diluted).  This compares with net income of  $1,507,000,  or $.15 per
share in 1996. Net income in the United States was $2,177,000 in 1997,  compared
to $1,686,000 in 1996.  Net income from  international  operations was a loss of
$148,000 in 1997, compared with a loss of $179,000 in 1996.

         Net sales  increased  in 1997 to $46.8  million,  as  compared to $40.7
million  in 1996,  as a result of the 21  percent  increase  in net sales in the
United States from $34.4 million in 1996 to $41.7 million in 1997.  Net sales in
the  United  States,  which  accounts  for 89  percent  of total net  sales,  is
comprised of network marketing sales and contract  packaging  services.  In 1997
network  marketing  sales in the United States  increased by 29 percent to $40.2
million  compared  to $31.1  million  in 1996,  while  net sales  from  contract
services  declined to $1.5 million  from $3.3 million in 1996.  Net sales in the
foreign operations declined to $5.1 million in 1997 from $6.3 million in 1996.

         Net sales for the fourth quarter of 1997 were $10.9 million, a decrease
from fourth quarter 1996 net sales of $12.0  million.  During the period network
marketing sales in the United States increased to $9.6 million from $9.1 million
in the fourth quarter 1996. The decrease in net sales was due to declines in net
sales in the  foreign  operations  from $1.8  million for the quarter in 1996 to
$1.2 million, and in contract packaging services from $1.1 million to $150,000.

         The Company provides contract packaging  services,  including blending,
processing  and  packaging  food  products  in  accordance  with  specifications
provided by its customers.  Net sales declined in 1997 to $1.5 from $3.3 million
in 1996.  The  decrease  was due to the  loss of a  substantial  customer  whose
business has not been  replaced.  To address this the Company has  established a
management  team  charged with  increasing  sales of contract  services,  and is
increasing its sales and marketing  efforts in this area. In addition to another
source of income,  providing  contract  services  allows  the  Company to better
utilize the manufacturing and product development infrastructure, thus spreading
overhead costs.

         The increase in network  marketing  sales during 1997 was a result of a
larger and more  productive  network of  distributors,  primarily  in the United
States. In the United States, the Company's largest market, the number of active
distributors  increased 12 percent to 29,616. The retention rate of distributors
who renew their annual agreement continued to remain high at 49 percent.  Master
Affiliates, distributors who have attained the highest level of discount and are
eligible for  generation  royalties,  increased to 3,631 in the United States in
1997 from  2,487 in 1996.  In 1997 the  Company  processed  73,136  orders at an
average retail price of $695, compared to 53,391 orders at an average of $733 in
1996.





                                       17




         The positive changes in the sales  organization was a result of several
sales and marketing  programs  coordinated to motivate and train distributors at
all levels of the distributor organization.  One element was the continued focus
on the Road to  Presidential,  designed to encourage  distributors  to reach the
highest level of earnings  potential by building their  downline  organizations.
This program was  initially  introduced in the United States in 1995 and then in
the foreign subsidiaries  throughout 1996. The Company believes the training and
rewards of this program  have  contributed  to the  increase in sales.  The Star
Director Program,  which reinforces the Road to Presidential,  was introduced in
June 1996.  This program  compensates  distributors  who reach certain levels of
sales  organization  growth  with  bonuses  based on the  retail  sales of their
distributor network. In 1997,  $1,329,000 was paid through this program compared
to $420,000 in 1996.  Another  ingredient  in the sales growth is the success of
the Ambassador Program, which compensates distributors at the highest levels for
their leadership and development of sales. At year end 1997 there were fifty-two
Ambassadors who shared in bonuses totaling $838,000.

         The  Company's  Direct  Select  Program  makes  products  available  to
consumers by ordering directly through the Company.  In 1997, the program in the
United  States,  produced  $5.9  million,  or nearly 10 percent of total product
sales at retail value,  compared to $4.3 million in 1996. The Company introduced
the Direct Select Program in Canada in October 1997 and plans an introduction in
Australia in early 1998.

         The United States 1997 net sales were affected by the  introductions of
two new  products,  Healthy  Pantry  Premium  Entrees,  a line of four  hot meal
products based on the use of soy protein,  and  Provantage,  a sports  nutrition
product  targeted for the fitness  market.  Both  products  expand the Company's
product line in the growing functional foods category.

         1997 network marketing sales strengthened throughout the United States.
Sales  remained  strong in the top ten states,  which  account for 64 percent of
total  sales,  with an increase of 20 percent in these  states when  compared to
1996 sales.  Sales in the other  states  increased  44 percent  over 1996 levels
indicating the Company is developing  strong markets outside its primary states.
Illinois,  Michigan and California  were the Company's  primary  markets in 1997
contributing 31 percent of total sales, a decrease of 4 percent when compared to
the top three markets in 1996. The above trends  indicate a more diverse base of
sales growth.

         In Australia  and New Zealand net sales  declined to $3,449,000 in 1997
from  $4,723,000 in 1996.  Fourth quarter 1997 sales  decreased to $753,000 from
$1,260,000 in 1996. New  distributor  enrollments  declined in Australia and New
Zealand to 1,820 from 3,108 in 1996.  Distributor renewals in Australia were 48%
and in New Zealand 37% in 1997 as compared to 41% and 36% in 1996, respectively.
Reported  net sales in  Australia  and New  Zealand  were also  affected  by the
decline in the value of their  currency as compared to the United States dollar.
During the year, both the Australian and New Zealand  dollars  declined 18% from
their rates as of December 31, 1996.

         The Company has taken  several steps to reverse the decline in sales in
Australia and New Zealand, as well as all its foreign  operations.  A management
team has been put in place with sole  responsibilities  for developing growth in
the  foreign  operations.  Previously,  the  responsibilities  for  the  foreign
operations fell under the management team  responsible for the United States and








                                       18




the holding company,  Reliv International.  The Company believes  establishing a
management  team with direct  responsibility  will  improve the efforts  towards
building successful sales operations.

         One element of this has been to replace the  Australian and New Zealand
sales manager with the Company's  International  Marketing Manager, who has been
employed  with the  Company  for  seven  years  and  served  as sales  manger of
Australia and New Zealand from 1991 through 1994.  During that period the market
grew in net sales from a start-up  to  $9,353,000  in 1994.  In late 1994 he was
promoted to International  Marketing Director and relocated to the United States
and contributed to the growth in the United States.

         Sales in  Australia  and New Zealand  have been  affected by  continued
delays in the  introduction of several new products due to regulatory  policies,
plus  increased  levels of  competition.  The Company has  received  approval in
Australia  and New Zealand to sell Reliv'  Classic and plans to  introduce it in
April  1998.  Reliv'  Classic is the number  one  selling  product in the United
States  accounting for approximately  25% of total retail sales.  Fibrestore,  a
product  which  averages  in excess of 10% of sales in the  United  States,  was
introduced in Australia in  September,  1997.  Both are strong  additions to the
product line. The Company plans to continue  building the product lines in these
countries during 1998.

         Net sales in Canada  increased in 1997 to $1,338,000 from $1,247,000 in
1996. Fourth quarter sales decreased to $334,000 in 1997 compared to $416,000 in
1996.  Fourth quarter net sales in 1996 were impacted by a sales  promotion that
created a large one time sales increase. New distributor enrollments declined to
991 from  1,165 in 1996.  The 1996 net  sales in  Canada  were  affected  by the
introductions  of  Reliv  A-Affect,  a  product  similar  to the  United  States
Arthaffect  that's designed to  nutritionally  support bone and joint conditions
and Direct  Select.  A-Affect  currently  represents 7 percent of total  product
sales. The Company believes  Canadian sales will be positively  affected in 1998
with the  addition  of Classic in March  1998 and future  product  introductions
throughout  1998.  Direct  Select,  introduced  in October  1997,  accounts  for
approximately 7.5 percent of total retail sales at year end.

         In Mexico net sales  declined  slightly  as the  economy  continued  to
contribute  to  Reliv  Mexico's  inability  to  increase  net  sales  and  reach
profitability.  Net sales in Mexico in 1997 were $330,000,  compared to $352,000
in 1996. Net sales in the fourth quarter 1997 were $74,000  compared to $103,000
in 1996. New distributor  enrollment  declined in 1997 to 360 compared to 487 in
1996.  In  response,  the  Company  introduced  a  revision  to the  distributor
compensation  plan in August 1997 to adjust for the devaluation of the peso. The
Company  believes the change will make the plan  competitive  with other network
marketing companies in Mexico.

         The Company began marketing its products in the United Kingdom in July,
1995, through a licensee.  Revenues under the license agreement in 1996 and 1997
were minimal and in February, 1998, the Company through its subsidiaries assumed
ownership and control of the United Kingdom operations. The Company believes its
direct management will improve sales efforts in this region.

         The Company believes that its computer  hardware and software will meet
is administrative  needs in the United States and in its foreign subsidiaries in
the foreseeable  future. The Company does not anticipate  significant changes to
its computer system or material expenses to comply with year 2000.






                                       19



1996 vs. 1995

         The Company's  1996 net income was  $1,507,000 or $ .15 per share ($.15
per share diluted). This compares with net income of $570,000, or $.06 per share
in 1995.  Net income in the United States was  $1,686,000  in 1996,  compared to
$430,000  in  1995.  Net  income  from  international  operations  was a loss of
$179,000 in 1996, compared with gain of $140,000 in 1995.

         The  increase  in net  income as  compared  to 1995 is a result of a 41
percent  increase  in net sales in 1996 to $40.7  million,  as compared to $28.9
million in 1995. Net sales in the United States  increased to $34.4 million from
$22.2  million  in 1995,  while net  sales in the  foreign  operations  declined
slightly  to $6.3  million in 1996 from $6.7  million in 1995.  Net sales in the
United States in 1996 were comprised of $31.1 million in network marketing sales
and $3.3 million in contract packaging services.  Net sales in the United States
in 1995  consisted of $21.9 million in network  marketing  sales and $279,000 in
contract packaging sales.

         In the fourth  quarter of 1995,  the Company began  providing  contract
packaging services,  including blending,  processing and packaging food products
in accordance  with  specifications  provided by its customers.  Direct costs of
contract  packaging  services  were 93 percent  of  revenue.  Direct  costs as a
percent of revenue  improved  throughout  the year from 108 percent in the first
quarter, to 84 percent in the fourth quarter.

         In 1996  network  marketing  activity in the United  States  16,622 new
distributors  enrolled and 10,305  distributors  renewed their  distributorship,
compared to 14,653 new  distributors  and 5,470  renewals  in 1995.  The average
wholesale order size in the U.S. (at retail)  increased in 1996 to $733 compared
to $670 in 1995.

         The United States 1996 net sales were affected by product introductions
of Reliv' Celleboost and the Getabetterbody weight loss system, in January 1996,
Cool Punch Innergize, in June 1996 and Arthaffect, in October 1996. In 1996, the
Direct Select program  produced sales at retail value of $4.3 million,  compared
to retail sales of $2.6 million in 1995.

         In Australia  and New Zealand net sales  declined to $4,723,000 in 1996
from  $5,760,000 in 1995.  Sales in Australia  and New Zealand  during 1996 have
been affected by continued  delays in the  introduction  of several new products
due  to  regulatory  policies,   plus  increased  levels  of  competition.   New
distributor  enrollments  declined  in  Australia  and New Zealand to 3,108 from
4,373 in 1995. Distributor renewals in Australia were 41% and in New Zealand 36%
in 1996 as compared to 38% and 29% in 1995, respectively.

         Net sales in Canada  increased in 1996 to  $1,247,000  from $494,000 in
1995. New distributor  enrollments increased to 1,165 from 376 in 1995. The 1996
net sales in Canada  were  affected by the  introductions  of Reliv  Optain,  an
isotonic  drink  similar  to the  Innergize  sold  in  the  United  States,  and
Celleboost, in January 1996.

         In Mexico  net  sales  declined  as the  economy  contributed  to Reliv
Mexico's inability to increase net sales and reach  profitability.  Net sales in
Mexico in 1996 were  $352,000,  compared to $436,000 in 1995 and  $1,008,000  in







                                       20


1994. The Company offset the currency  devaluation  with a price increase of its
products that hindered the ability to sell the product and therefore contributed
to the reduction in sales.  New distributor  enrollment  declined in 1996 to 487
compared to 1,001 in 1995


Cost of Sales:

         During 1997,  cost of network  marketing  products  sold improved to 18
percent of net sales  compared with 19 percent in 1996,  and 21 percent in 1995.
The  improvement  in gross  profit  margins  is a result of lower raw  materials
costs,  improved  manufacturing  controls  and  utilization  of the  facility in
providing contract  manufacturing  services.  Cost of network marketing products
sold was  constant  at 17 percent in the fourth  quarter of 1997 and in the same
period in 1996. Cost of goods for contract services improved for the year to 89%
from 93% in 1996. The Company expanded its facility in 1997 adding approximately
60,000 square feet of warehouse and  manufacturing  space.  The expansion  space
will be put into full operation during the first half of 1998.


Distributor Royalties and Discounts:

         Distributor   royalties  and  discounts  as  a  percentage  of  network
marketing sales increased to 37 percent in 1997 from 36 percent in 1996.  Fourth
quarter 1997  distributor  royalties and discounts  also increased to 37 percent
from 36  percent  in  1996.  These  expenses  are  governed  by the  distributor
agreements  and are directly  related to the level of sales.  The Company pays a
percentage  of sales up to 18 percent in royalties  and as much as 45 percent in
commissions.  The 1997 increase compared to 1996 is partly due to an increase in
net sales from the Company's  Direct Select program.  Sales in the Direct Select
Program  increased to $5.9 million from $4.3 million in 1996.  In this  program,
customers  purchase  directly  from the  Company  at full  retail  price and the
Company distributes to the distributor force 45 percent of the purchase price as
a  commission  earned.  This is higher than the average  commission  paid by the
Company to distributors for purchases made at wholesale  price. In addition,  in
1997, the Company paid royalties of $838,000  through the Ambassador  Program as
compared to $631,000 in 1996.


Selling, General and Administrative:

         Selling,  general and  administrative  expenses  increased  to 37% as a
percentage of net sales for 1997,  from 36 percent in 1996, but less than the 39
percent  in 1995.  The  change in 1997 is  primarily  a result of  increases  in
selling expenses, professional services and staff compensation.


         In 1997,  sales  meetings and convention  expenses were  $1,200,000 and
sales promotion  incentives were $489,000,  compared to $845,000 and $342,000 in
1996,   respectively.   The  Star  Director  program,   which  rewards  eligible
distributors  with a bonus  based  on the  retail  sales  of  their  distributor
network,  paid  $1,329,000 in 1997 compared to $420,000 in 1996. The program was
introduced in June 1996 and has a limit of 3% of total product retail sales.  In
1997 2.2 percent was paid.






                                       21



         Consulting and professional  services increased $357,000 to $642,000 in
1997  as the  Company  increased  its  use of  marketing  and  public  relations
companies.  The  Company  does not  anticipate  the level of these  expenses  to
continue at 1997 levels. Staff compensation  increased by 15 percent,  primarily
in  the  sales,  marketing  and  distribution  departments.   These  departments
increased 50 percent in order to service the sales  growth in the United  States
and contribute additional support to the foreign operations.

         Selling,  general and  administrative  expenses as a percentage  of net
sales were higher in the fourth  quarter 1997 as expenses were 39 percent of net
sales compared to 35 percent during the fourth quarter 1996. The decrease in net
revenues from $12,044,000 in 1996 to $10,915,000 is the primary reason,  as well
the items mentioned above.


Interest Expense:

         Interest expense in 1997 was $210,000  compared to $213,000 in 1996 and
$146,000 in 1995.  Interest  expense in 1998 will increase due to a loan package
secured for the expansion of the Company's  office and  manufacturing  facility,
plus the lease of furnishings  and  equipment.  Short-term  debt,  capital lease
obligations and long-term debt increased to $5,507,000 from $1,761,000 in 1996.

Other Income/Expense:

         Other income  decreased  to $113,000 in 1997 from  $147,000 in 1996 and
$226,000  in 1995.  This is due to a  decrease  in  interest  earned  from  cash
investments  made by the  Company  in  interest-bearing  accounts  or  financial
instruments and foreign exchange gains in 1995.


Income Taxes:

         The provision for income taxes increased to $1,385,000,  or 3.0 percent
of net sales in 1997,  from 2.3 percent of net sales or $950,000 in 1996, and .6
percent of net sales,  or $187,000 in 1995.  The effective tax rate for 1997 was
41  percent.  Effective  tax  rates  for 1996 and 1995  were 39  percent  and 25
percent,  respectively.  The  effective  rate for 1995 was lower than the United
States  statutory  rates as a result of the  conversion  of Reliv'  Canada to an
unlimited liability company in 1995. The 1997 effective rate was slightly higher
than 1996 as the result of the  settlement  of an audit by the Internal  Revenue
Service for the fiscal years 1992 through 1994.


Financial Condition
- -------------------

         The Company generated cash flow of $2,491,000 from operating activities
during  1997 and  $3,959,000  through  long-term  financing.  This  compares  to
$2,122,000  generated from operating  activities and $364,000 through  long-term
financing in 1996. Cash and cash equivalents increased $318,000 to $2,426,000 by
year-end  1997.  The  Company  invested  $5,055,000  in its  facility,  with the
construction  of  approximately  90,000 square feet of office and  manufacturing
space,  and the  acquisition  of office  furnishings  and plant  equipment.  The
Company used $337,000 to  repurchase  shares of its common stock and $293,000 to
pay dividends.





                                       22



         Current  assets  increased  to  $6,745,000  at  December  31, 1997 from
$6,553,000 as of December 31, 1996. Cash and cash equivalents increased $318,000
as described above.  Accounts receivable  decreased by $190,000 to $866,000 from
the  December  31, 1996  balance of  $1,056,000  as a result of the  decrease in
contract  packaging  services,  which  are  generally  paid  on  30  day  terms.
Inventories declined slightly to $2,642,000 from $2,762,000 at year end 1996.

         Property, plant and equipment, after dispositions, increased $4,926,000
to  $11,922,000  at  December  31,  1997,  as a result of the  expansion  of its
facility.  The  Company  does not  anticipate  significant  purchases  of plant,
property and equipment in 1998.

         Current  liabilities  decreased to $3,653,000 at December 31, 1997 from
$3,866,000 at December 31, 1996. Trade accounts payable  decreased to $1,433,000
from  $1,689,000  at  December  31,  1996  primarily  due  to  the  decrease  in
inventories.  Distributor  commissions payable increased $263,000 as a result of
improved net sales as compared to December 31, 1996. Accrued payroll and payroll
taxes  decreased  to $174,000 at December  31, 1997 from  $392,000 for the prior
year end,  primarily due to $240,000 in accrued incentive  compensation that was
included at December 31, 1996.

         Long-term debt increased to $5,149,000  from $1,478,000 at December 31,
1996. The Company  entered into a loan agreement of $4,430,000 in September 1997
to  provide  financing  for  the  expansion  of its  facility.  The  term of the
agreement  is three  years with a 20 year  payment  amortization  schedule.  The
Company has a term loan with a principal  balance of $662,000 as of December 31,
1997, as well as long-term debt totalling $803,000,  relating to the purchase of
its original  building and land.  The Company  also has two  operating  lines of
credit in the amounts of  $800,000  and  $500,000.  At December  31,  1997,  the
Company was not utilizing the lines of credit. As a result of the increased long
term debt, the Company's ratio of total liabilities to total assets increased to
55% from 47% at December 31, 1996.

         Stockholders'  equity  increased  to $7.2  million  compared  with $6.1
million in 1996.  The  improvement is due to the 1997 net income of the Company.
On January  31,  1997,  the  Company  declared a 10% stock  dividend  and a cash
dividend of $0.01 per share paid on February  28,  1997 to  recordholders  as of
February 14,  1997.  The stock  dividend  resulted in a transfer  from  retained
earnings  to the common  stock  account in the amount of  $5,848,000,  which was
based on the closing price of $6.50 per share of Common Stock on the declaration
date.  Average  shares  outstanding  and all per share  amounts  included in the
accompanying  consolidated  financial statements and notes reflect the increased
number of shares as a result of the stock  dividend.  During  1997,  the Company
paid cash dividends of $293,000.

         The Company's  working  capital  balance has improved by $405,000 since
December 31, 1996.  The current ratio at December 31, 1997 improved to 1.85 from
1.7. Management believes that the Company's  internally generated funds together
with the loan agreement will be sufficient to meet working capital  requirements
in 1998.

         Forward-looking  statements made in this filing involve  material risks
and  uncertainties  that  could  cause  actual  results  and  events  to  differ
materially from those set forth, or implied,  including the Company's ability to








                                       23



continue to attract,  maintain  and motivate  its  distributors,  changes in the
regulatory  environment  affecting network marketing sales and sales of food and
dietary supplements and other risks and uncertainties  detailed in the Company's
other SEC filings.



Item No. 8 - Financial Statements and Supplementary Data
- --------------------------------------------------------

         Reference is made to the Consolidated Financial Statements contained in
Part IV hereof.


Item No. 9 - Changes in and  Disagreements  with  Accountants  on Accounting and
- ----------------------------------------------------------------------------
         Financial Disclosure
         --------------------

     None.


PART III

Item No. 10 - Directors and Executive Officers of the Registrant
- ----------------------------------------------------------------

Information  called for by Item 10 of Part III is  incorporated  by reference to
the definitive Proxy Statement for the 1998 Annual Meeting of Shareholders to be
held on May 21, 1998, to be filed with the Commission within 120 days of the end
of the Company's last fiscal year.


Item No. 11 - Executive Compensation
- ------------------------------------

Information  called for by Item 11 of Part III is  incorporated  by reference to
the definitive Proxy Statement for the 1998 Annual Meeting of Shareholders to be
held on May 21, 1998, to be filed with the Commission within 120 days of the end
of the Company's last fiscal year.


Item No. 12 - Security Ownership of Certain Beneficial Owners and Management
- ----------------------------------------------------------------------------

Information  called for by Item 12 of Part III is  incorporated  by reference to
the definitive Proxy Statement for the 1998 Annual Meeting of Shareholders to be
held on May 21, 1998, to be filed with the Commission within 120 days of the end
of the Company's last fiscal year.


Item No. 13 - Certain Relationships and Related Transactions
- ------------------------------------------------------------

Information  called for by Item 13 of Part III is  incorporated  by reference to
the definitive Proxy Statement for the 1998 Annual Meeting of Shareholders to be
held on May 21, 1998, to be filed with the Commission within 120 days of the end
of the Company's last fiscal year.




                                       24





PART IV
- -------

Item No. 14 - Exhibits, Financial Statement Schedules and Reports on Form 8K
- ----------------------------------------------------------------------------

          (a)        1.    The Consolidated  Financial  Statements filed as part
                           of this  report  on  Form  10-K  are  listed  on  the
                           accompanying   Index   to   Consolidated    Financial
                           Statements and Consolidated Financial Statement
                           Schedules.

                     2.    The  Consolidated Financial Statement Schedules filed
                           as part of this report on Form 10-K are listed on the
                           accompanying   Index   to   Consolidated    Financial
                           Statements  and  Consolidated   Financial   Statement
                           Schedules.

                     3.    Exhibits:

                                                                 Exhibit
                  Document                                       Number
                  --------                                       ------

         Articles of Incorporation, as amended
         (incorporate by reference Exhibit 3.1 to
         the Form 10-K of the Registrant for year
         ended December 31, 1995)                                  3.1

         By-laws, as amended
         (incorporate by reference Exhibit 3.2
         to the Form 10-K of the Registrant for
         year ended December 31, 1992)                             3.2

         Amended Exclusive License Agreement
         (incorporate by reference Exhibit 10.1
         to the Form 10-K of the Registrant
         for year ended December 31, 1992)                        10.1

         Asset Purchase Agreement
         (Australian Joint Venture)
         (incorporate by reference Exhibit 10.2
         to the Form 10-K of the Registrant
         for year ended December 31, 1992)                        10.2

         Master Agent Agreement
         (re: Australia)
         (incorporate by reference Exhibit 10.3
         to the Form 10-K of the Registrant for year
         ended December 31, 1992)                                 10.3

         Tobin Stock Purchase Agreement
         (incorporate by reference Exhibit 10.6
         to the Form 10-K of the Registrant
         for year ended December 31, 1992)                        10.4






                                       25



                                                                 Exhibit
                  Document                                       Number
                  --------                                       ------

         Tobin Consulting Agreement
         (incorporate by reference Exhibit 10.7
         to the Form 10-K of the Registrant
         for year ended December 31, 1992)                        10.5

         1995 Stock Option Plan  (incorporate by   
         reference Exhibit 10.7 to the
         Form 10-K of the Registrant for year
         ended December 31, 1995)                                 10.6

         Montgomery Employment Agreement
         dated June 1, 1997                                       10.7

         Hastings Employment Agreement
         dated June 1, 1997                                       10.8

         Kreher  Employment Agreement dated  
         April 13, 1994 (incorporate by
         reference Exhibit 10.14 to the 
         Registrant's Form 10-Q for 
         quarter ended June 30, 1994).                            10.9

         1994 Annual Incentive Compensation Plan  
         (incorporate by reference Exhibit 10.11  
         to the Form 10-K of the Registrant for
         year ended December 31, 1995)                            10.10

         1994 Long-Term Incentive Compensation Plan 
         (incorporate by reference Exhibit 10.12 to 
         the Form 10-K of the Registrant for 
         year ended December 31, 1995)                            10.11

         Agreement with Avogen, Inc. dated July 1, 1995
         (incorporate by reference Exhibit 10.13 to the
         Form 10-K of the Registrant for year ended
         December 31, 1995)                                       10.12

         Agreement with Conkle & Olesten and Avogen, Inc.
         dated July 1, 1995 (incorporate by reference 
         Exhibit 10.14 to the Form 10-K of the Registrant 
         for year ended December 31, 1995)                        10.13





                                       26


                                                                 Exhibit
                  Document                                       Number
                  --------                                       ------

         Agreement with Traco Labs, Inc.
         (incorporated by reference Exhibit 10.14
         to the Form 10-K of the Registrant for
         year ended December 31, 1996)                            10.14

         Amendment to Avogen and Conkle & Oleston
         Agreements dated April 25, 1997                          10.15

         Statement re: computation of per
         share earnings (incorporated by reference
         to Note 7 of the Consolidated Financial
         Statements contained in Part IV)                         11

         Subsidiaries of the Registrant
         (incorporate by reference the
         the Registrants's Response to
         Item 1 of Part I of this Form 10-K)                      22

         Consent of Ernst & Young L.L.P.,
         Independent Auditors                                     23

         (b)      N/A

         (c)      The Exhibits listed in subparagraph (a)(3) of this Item 14 are
                  attached  hereto.   Unless  incorporated  by  reference  to  a
                  previous filing.

         (d)      The Schedules listed in  subparagraph (a)(2) of this  Item  14
                  are attached hereto.







                                       27



         SIGNATURES

         Pursuant to the  requirements  of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.

                  RELIV' INTERNATIONAL, INC.
                  --------------------------



By:              /s/Robert L. Montgomery
         ----------------------------------------------------------------------
         Robert L. Montgomery, Chairman of the Board of Directors, President and
         Chief Executive Officer, Treasurer

Date:    March 27, 1998

         Pursuant to the requirements of the Securities Act of 1934, this report
has been signed by the following  persons on behalf of the registrant and in the
capacities and on the dates indicated.

By:              /s/Robert L. Montgomery
         ----------------------------------------------------------------------
         Robert L. Montgomery, Chairman of the Board of Directors, President and
         Chief Executive Officer, Treasurer

Date:    March 27, 1998


By:           /s/ David G. Kreher
         ----------------------------------------------------------------------
         David  G. Kreher,  Senior  Vice  President,  Chief  Operating  Officer,
         Assistant Secretary
         (principal financial and accounting officer)

Date:    March 27, 1998


By:          /s/ Carl W. Hastings
         ----------------------------------------------------------------------
         Carl  W. Hastings,   Executive  Vice  President,   Assistant Secretary,
         Director

Date:    March 27, 1998


By:         /s/ Thomas W. Pinnock
         ----------------------------------------------------------------------
         Thomas W. Pinnock III, Director

Date:    March 27, 1998


By:         /s/ Stephen M. Merrick
         ----------------------------------------------------------------------
         Stephen M. Merrick, Secretary, Director

Date:    March 27, 1998






                                       28



By:            /s/ Donald L. McCain
         ----------------------------------------------------------------------
         Donald L. McCain, Director

Date:    March 27, 1998


By:           /s/ John Akin
         ----------------------------------------------------------------------
         John Akin, Director

Date:    March 27, 1998


By:          /s/ Sandra S. Montgomery
         ----------------------------------------------------------------------
         Sandra S. Montgomery, Director

Date:    March 27, 1998


By:         /s/ Thomas T. Moody
         ----------------------------------------------------------------------
         Thomas T. Moody, Director

Date:    March 27, 1998


By:        /s/ Marvin W. Solomonson
         ----------------------------------------------------------------------
         Marvin W. Solomonson, Director

Date:    March 27, 1998


                                       29







                           Reliv' International, Inc.
                                and Subsidiaries

                        Consolidated Financial Statements


                  Years ended December 31, 1997, 1996 and 1995




                                    Contents

Consolidated Financial Statements:
  Report of Independent Auditors........................................... F-1
  Consolidated Balance Sheets as of December 31, 1997 and 1996............. F-2
  Consolidated Statements of Income for the years ended
     December 31, 1997, 1996 and 1995...................................... F-4
  Consolidated Statements of Stockholders' Equity for the years ended
     December 31, 1997, 1996 and 1995...................................... F-5
  Consolidated Statements of Cash Flows for the years ended
    December 31, 1997, 1996 and 1995....................................... F-6
  Notes to Consolidated Financial Statements - December 31, 1997........... F-8

Financial Statement Schedule:
  Schedule II - Valuation and Qualifying Accounts for the years ended
    December 31, 1997, 1996 and 1995....................................... F-29

All other  schedules for which  provision is made in the  applicable  accounting
regulation of the Securities and Exchange  Commission are not required under the
related instructions or are inapplicable and, therefore, have been omitted.





                      [LETTERHEAD OF ERNST & YOUNG L.L.P.]



                         Report of Independent Auditors




Board of Directors and Stockholders
Reliv' International, Inc.

We  have  audited  the  accompanying   consolidated  balance  sheets  of  Reliv'
International,  Inc. and  subsidiaries as of December 31, 1997 and 1996, and the
related consolidated  statements of income,  stockholders' equity and cash flows
for each of the three years in the period ended  December  31, 1997.  Our audits
also  included  the  financial  statement  schedule  listed in the Index at Item
14(a).  These financial  statements and schedule are the  responsibility  of the
Company's  management.  Our  responsibility  is to  express  an opinion on these
financial statements and schedule based on our audits.

We  conducted  our  audits  in  accordance  with  generally   accepted  auditing
standards.  Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated  financial statements referred to above present
fairly, in all material respects,  the consolidated financial position of Reliv'
International,  Inc. and  subsidiaries  at December  31, 1997 and 1996,  and the
consolidated  results of their  operations  and their cash flows for each of the
three years in the period ended December 31, 1997, in conformity  with generally
accepted  accounting  principles.  Also, in our opinion,  the related  financial
statement  schedule,   when  considered  in  relation  to  the  basic  financial
statements  taken as a whole,  presents  fairly  in all  material  respects  the
information set forth therein.


                                   /s/ Ernst & Young L.L.P.


March 17, 1998
St. Louis, Missouri


                                       F-1






                   Reliv' International, Inc. and Subsidiaries

                           Consolidated Balance Sheets




                                                                          December 31
                                                                     1997              1996
                                                                ------------------------------

                                                                              
Assets
Current assets:       
   Cash and cash equivalents                                    $  2,426,426      $  2,108,770
   Accounts and notes receivable,
     less allowances of $7,600
     in 1997 and $13,000 in 1996                                     865,701         1,056,360
   Inventories:
     Finished goods                                                1,453,282         1,219,295
     Raw materials                                                   785,706         1,136,897
     Sales aids and promotional materials                            403,830           405,768
                                                                ------------------------------
                                                                   2,642,818         2,761,960

   Refundable income taxes                                            31,303            48,949
   Prepaid expenses and other current assets                         688,539           512,031
   Deferred income taxes                                              90,065            65,000
                                                                ------------------------------
Total current assets                                               6,744,852         6,553,070

Deferred costs                                                         4,232            79,223

Property, plant and equipment:
   Land                                                              790,677           790,677
   Building                                                        2,854,548         2,863,457
   Machinery and equipment                                         1,723,482         1,693,849
   Office equipment                                                  303,235           328,780
   Computer equipment and software                                 1,452,577         1,245,137
   Construction in progress                                        4,797,090            74,423
                                                                ------------------------------
                                                                  11,921,609         6,996,323
   Less accumulated depreciation and amortization                 (2,700,745)       (2,226,951)
                                                                ------------------------------
                                                                   9,220,864         4,769,372
                                                                ------------------------------
                                                                $ 15,969,948      $ 11,401,665
                                                                ==============================
                                                                                 



See accompanying notes.

                                       F-2





                   Reliv' International, Inc. and Subsidiaries

                           Consolidated Balance Sheets




                                                                          December 31
                                                                     1997              1996
                                                                ------------------------------

                                                                             
Liabilities and stockholders' equity 
Current liabilities:
   Accounts payable and accrued expenses                        $  3,290,131      $  3,496,058
   Income taxes payable                                                 --              65,102
   Current maturities of long-term debt and
     capital lease obligations                                       358,124           282,502
   Unearned income                                                     5,003            22,602
                                                                ------------------------------
Total current liabilities                                          3,653,258         3,866,264

Capital lease obligations, less current maturities                    39,105            13,211
Long-term debt, less current maturities                            5,109,520         1,464,868



Stockholders' equity:
   Common stock, no par value; 20,000,000 shares authorized,
     9,617,307 shares issued and outstanding in 1997 and
     9,900,529 shares issued and outstanding in 1996               9,135,764         9,211,826
   Notes receivable - officers and directors                          (4,633)           (4,633)
   Retained earnings (deficit)                                    (1,673,164)       (2,516,181)
   Foreign currency translation adjustment                          (289,902)           10,970
   Less cost of treasury stock - 250,580 shares in 1996                 --            (644,660)
                                                                ------------------------------
                                                                   7,168,065         6,057,322



                                                                ------------------------------
                                                                $ 15,969,948      $ 11,401,665
                                                                ==============================
                                                                     



See accompanying notes.


                                       F-3





                   Reliv' International, Inc. and Subsidiaries

                        Consolidated Statements of Income


                                                           Year ended December 31
                                                     1997            1996            1995
                                                --------------------------------------------


                                                                                
Sales at suggested retail                       $ 71,066,845    $ 60,840,620    $ 46,466,287
Less distributor allowances on
   product purchases                              24,230,575      20,110,627      17,552,414
                                                --------------------------------------------
Net sales                                         46,836,270      40,729,993      28,913,873

Costs and expenses:
   Cost of products sold                           9,404,283      10,193,418       6,386,806
   Distributor royalties and commissions          16,837,084      13,429,386      10,678,500
   Selling, general and administrative            17,083,792      14,585,127      11,171,344
                                                --------------------------------------------
                                                  43,325,159      38,207,931      28,236,650
                                                --------------------------------------------
Income from operations                             3,511,111       2,522,062         677,223

Other income (expense):
   Interest expense                                 (210,268)       (212,819)       (146,476)
   Other income                                      113,145         147,771         226,076
                                                --------------------------------------------
Income before income taxes                         3,413,988       2,457,014         756,823
Provision for income taxes                         1,385,000         950,000         187,000
                                                --------------------------------------------
Net income                                      $  2,028,988    $  1,507,014    $    569,823
                                                ============================================
                                                                             

Basic earnings per share (1)                          $  .21          $  .15          $  .06

Diluted earnings per share (1)                        $  .20          $  .15          $  .06

<FN>

(1) Per  share  data for 1996 and 1995  reflects  the pro  forma  effect  of the
Company's 10 percent stock dividend declared on January 31, 1997 and distributed
on February 28, 1997.
</FN>





See accompanying notes.





                                       F-4





                   Reliv' International, Inc. and Subsidiaries

                 Consolidated Statements of Stockholders' Equity






                                                                           Notes                   Foreign       
                                                     Common Stock       Receivable -   Retained    Currency        Treasury Stock
                                                ----------------------  Officers and   Earnings   Translation     ------------------
                                                   Shares       Amount   Directors    (Deficit)    Adjustment    Shares     Amount
                                                ---------------------------------------------------------------------------------- 
                                                                                                           
Balance at December 31, 1994                     9,472,913   $3,460,308  $(10,523)   $ 2,739,422    $  60,202    266,252  $(623,380)
   Common stock purchased for treasury                --           --        --             --           --      109,726   (365,544)
   Repayment of loans by officers and director        --           --       5,890           --           --         --         --
   Foreign currency translation adjustment            --           --        --             --       (139,836)      --         --
   Cancellation of treasury stock                 (161,612)     (47,322)     --         (500,776)        --     (161,612)   453,098
   Dividends paid ($.01 per share)                    --           --        --          (93,746)        --         --         --
   Net income                                         --           --        --          569,823         --         --         --
                                                 ---------------------------------------------------------------------------------- 
Balance at December 31, 1995                     9,311,301    3,412,986    (4,633)     2,714,723      (79,634)   214,366   (535,826)
                                                 ---------------------------------------------------------------------------------- 
   Common stock purchased for treasury                --           --        --             --           --      309,189   (823,808)
   Options exercised                                 8,113       10,266      --             --           --         --         --
   Foreign currency translation adjustment            --           --        --             --         90,604       --         --
   Cancellation of treasury stock                 (295,755)     (59,154)     --         (710,820)        --     (295,755)   714,974
   Dividends paid ($.02 per share)                    --           --        --         (179,370)        --         --         --
   Stock dividend declared January 31, 1997        876,870    5,847,728      --       (5,847,728)        --       22,780       --
   Net income                                         --           --        --        1,507,014         --         --         --
                                                 ---------------------------------------------------------------------------------- 
Balance at December 31, 1996                     9,900,529    9,211,826    (4,633)    (2,516,181)      10,970    250,580   (644,660)
                                                 ---------------------------------------------------------------------------------- 
   Common stock purchased for treasury                --           --        --             --           --       86,306   (337,127)
   Options exercised                                10,438       13,125      --             --           --         --         --
   Warrants exercised                               29,140         --        --             --           --         --         --
   Foreign currency translation adjustment            --           --        --             --       (300,872)      --         --
   Cancellation of treasury stock                 (314,106)     (89,187)     --         (892,600)        --     (314,106)   981,787
   Adjustment to stock dividend                     (8,694)        --        --             --           --      (22,780)      --
   Dividends paid ($.03 per share)                    --           --        --         (293,371)        --         --         --
   Net income                                         --           --        --        2,028,988         --         --         -- 
                                                 ---------------------------------------------------------------------------------- 
                                                                                                                         
Balance at December 31, 1997                     9,617,307   $9,135,764  $ (4,633)   $(1,673,164)   $(289,902)      --    $    --
                                                 ==================================================================================





See accompanying notes.



                                       F-5



                   Reliv' International, Inc. and Subsidiaries

                      Consolidated Statements of Cash Flows




                                                               Year ended December 31
                                                          1997           1996           1995
                                                    ------------------------------------------

                                                                           
Operating activities       
Net income                                           $ 2,028,988    $ 1,507,014    $   569,823
Adjustments to reconcile net income to
   net cash provided by operating activities:
     Depreciation and amortization                       607,281        629,157        452,141
     Provision for losses on accounts receivable            --           78,699           --
     Provision for deferred income taxes                 (31,096)        (1,974)        13,017
     Foreign currency translation loss                   (23,019)         3,169         27,315
     (Increase) decrease in accounts and notes
       receivable                                        185,115       (480,365)      (470,654)
     (Increase) decrease in inventories                   30,553       (216,431)       262,765
     (Increase) decrease in             
       refundable income taxes                            21,496        183,454         41,199
     (Increase) decrease in prepaid expenses and
       other current assets                             (183,098)       (61,861)      (187,073)
     (Increase) decrease in deferred costs                69,657         69,753       (122,689)
     Increase (decrease) in accounts payable and
       accrued expenses                                 (128,082)       480,944        324,388
     Increase (decrease) in income taxes payable         (68,940)       (77,890)      (102,824)
     Increase (decrease) in unearned income              (17,594)         7,839         (4,264)
                                                    ------------------------------------------   
Net cash provided by operating activities              2,491,261      2,121,508        803,144

Investing activities
Proceeds from the sale of property, plant and
   equipment                                              73,010            837           --
Purchase of property, plant and equipment             (5,054,726)      (765,386)    (1,330,083)
Proceeds from the sale of  investments                      --           81,969           --
Repayment of loans to officers and directors                --             --            5,890
                                                    ------------------------------------------
Net cash used in investing activities                 (4,981,716)      (682,580)    (1,324,193)

Financing activities
Proceeds from long-term borrowings and line of
   credit                                              3,958,514        363,887        662,297
Principal payments on long-term borrowings and
   line of credit                                       (220,144)      (171,097)      (112,236)
Principal payments under capital lease obligations       (84,723)       (59,230)       (61,774)
Proceeds from stock options exercised                     13,125         10,266           --
Dividends paid                                          (293,371)      (179,370)       (93,745)
Purchase of treasury stock                              (337,127)      (878,808)      (460,543)
                                                    ------------------------------------------
Net cash provided (used) by financing activities       3,036,274       (914,352)       (66,001)
Effect of exchange rate changes on cash and cash
   equivalents                                          (228,163)        77,018        (74,531)
                                                    ------------------------------------------
Increase (decrease) in cash and cash equivalents         317,656        601,594       (661,581)
Cash and cash equivalents at beginning of year         2,108,770      1,507,176      2,168,757
                                                    ------------------------------------------
Cash and cash equivalents at end of year             $ 2,426,426    $ 2,108,770    $ 1,507,176
                                                     =========================================
                                                                                






                                       F-6




                   Reliv' International, Inc. and Subsidiaries

                Consolidated Statements of Cash Flows (continued)





                                                                Year ended December 31
                                                          1997           1996           1995
                                                      ------------------------------------------

                                                                            
Supplemental disclosures of cash flow information:
   Cash paid during the year for:
     Interest (includes capitalized interest of
     $71,425)                                         $   219,997    $   217,698     $   138,404
                                                      ==========================================

     Income taxes                                     $ 1,396,476    $   845,632     $   346,931
                                                      ========================================== 

   Non cash investing and financing transactions:
     Capital lease obligations entered into           $    92,519    $      --       $    35,230
                                                     =========================================== 




See accompanying notes.













                                       F-7





                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements

                                December 31, 1997

1. Nature of Business and Significant Accounting Policies

Nature of Business

Reliv'  International,  Inc.  (the  Company)  produces  a line of food  products
including nutritional  supplements,  diet management products,  granola bars and
sports drink mixes.  The Company  also  distributes  a line of premium skin care
products.  These  products  are sold by  subsidiaries  of the Company to a sales
force of independent  distributors who sell products directly to consumers.  The
Company and its subsidiaries sell products to distributors throughout the United
States and in Australia,  Canada, New Zealand, Mexico and the United Kingdom. In
addition,  in the fourth quarter of 1995, the Company began  providing  contract
processing and packaging services.

Principles of Consolidation

The consolidated  financial  statements  include the accounts of the Company and
its foreign and domestic subsidiaries. All significant intercompany accounts and
transactions have been eliminated.

Inventories

Inventories  are  valued  at the  lower  of  cost  or  market.  Product  cost is
determined  using standard  costs,  which  approximate  the first-in,  first-out
basis. Other inventory cost is determined using the first-in, first-out basis.

Property, Plant and Equipment

Property,  plant and  equipment are stated on the cost basis.  Depreciation  and
amortization,  which includes the  amortization of assets recorded under capital
leases,  are computed using the  straight-line  or  accelerated  method over the
useful life of the related assets.

Deferred Costs

The costs of brochures,  design fees for product labels and  organization  costs
are  capitalized  and  amortized on a  straight-line  basis over the  respective
assets' useful lives, typically three to five years.





                                       F-8




                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


1. Nature of Business and Significant Accounting Policies (continued)

Revenue Recognition

The Company generally receives its sales price in cash accompanying  orders from
independent  distributors and makes related commission payments in the following
month.  The net sales price is the suggested  retail price less the  distributor
discount  of 25  percent to 45 percent of such  suggested  retail  price.  Sales
revenue and  commission  expense are recorded when the  merchandise  is shipped.
Unearned income represents  prepaid orders for which the Company has not shipped
the merchandise.


Foreign Currency Translation

Each foreign  subsidiary's assets and liability  accounts,  which are originally
recorded in the appropriate local currencies,  are translated into United States
dollar amounts at the year-end exchange rates.  Revenue and expense accounts are
translated at the average rates for the year.  Transaction gains and losses, the
amounts  of  which  are  immaterial,   are  included  in  selling,  general  and
administrative   expenses.   Foreign   exchange   translation   adjustments  are
accumulated in a separate component of stockholders' equity.

The foreign exchange  translation  adjustment for 1995 reflects the consolidated
effect on the  Company  resulting  from the  decline in the value of the Mexican
peso relative to the U.S. dollar of  approximately  36 percent in 1995. In 1996,
the Mexican  peso  remained  relatively  stable,  while the  Australian  and New
Zealand dollars improved from their 1995 levels. In 1997, the Australian and New
Zealand  dollars  declined  substantially  in the latter  half of the year.  The
magnitude  of the  effect on the  foreign  exchange  translation  adjustment  is
mitigated by the fact that the U.S. dollar denominated intercompany financing of
the  Mexican  subsidiary  is  considered  of  a  long-term   investment  nature.
Accordingly,  the  effect of  exchange  rate  fluctuations  on the  intercompany
financing is accumulated as a separate component of stockholders' equity.

Income Taxes

The  provision  for income taxes is computed  using the  liability  method.  The
primary difference  between financial  statement and taxable income results from
financial statement accruals and reserves.








                                       F-9



                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


1. Nature of Business and Significant Accounting Policies (continued)

Stock-Based Compensation

The Company  accounts for stock options in  accordance  with APB Opinion No. 25,
"Accounting  for Stock  Issued to  Employees."  Since the Company  grants  stock
options at an  exercise  price not less than the fair value of the shares at the
date of grant, no compensation  expense is recognized.  The Financial Accounting
Standards Board has issued  Statement of Financial  Accounting  Standards (SFAS)
No. 123, "Accounting and Disclosure of Stock-Based  Compensation," effective for
years  beginning  after  December  1995. The Company has elected to disclose the
effects of this  pronouncement in a footnote to these financial  statements (see
Note 8).


Basic and Diluted Earnings per Share

In 1997,  the Financial  Accounting  Standards  Board issued  Statement No. 128,
Earnings per Share.  Statement 128 replaced the calculation of primary and fully
diluted  earnings per share with basic and diluted  earnings  per share.  Unlike
primary  earnings  per share,  basic  earnings  per share  excludes any dilutive
effects of options,  warrants and convertible  securities.  Diluted earnings per
share is very similar to the  previously  reported  fully  diluted  earnings per
share.  All earnings per share amounts for all periods have been presented,  and
where appropriate, restated to conform to the Statement 128 requirements.

Basic earnings per common share is computed using the weighted average number of
common shares  outstanding during the year. Diluted earnings per common share is
computed  using the  weighted  average  number of common  shares  and  potential
dilutive  common  shares  that were  outstanding  during the  period.  Potential
dilutive  common shares consist of outstanding  stock options and warrants.  See
Note 7 for additional  information  regarding earnings per share. On January 31,
1997, the Company  declared a 10 percent stock dividend on the Company's  common
stock which was  distributed on February 28, 1997 to  shareholders  of record on
February 14, 1997. The dividend was transferred from retained earnings to common
stock in the amount of $5,848,000, which was based on the closing price of $6.50
per share on the declaration date.  Average shares outstanding and all per share
amounts included in the accompanying consolidated financial statements and notes
are based on the increased  number of shares giving  retroactive  recognition to
the stock dividend.







                                      F-10



                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


1. Nature of Business and Significant Accounting Policies (continued)

Advertising

Costs of sales aids and  promotional  materials are  capitalized as inventories.
All other advertising and promotional costs are expensed when incurred.


Cash Equivalents

The Company's  policy is to consider demand deposits and short-term  investments
with a maturity of three months or less when purchased as cash equivalents.

Use of Estimates

The preparation of financial  statements in conformity  with generally  accepted
accounting principles requires management to make estimates and assumptions that
affect the amounts reported in the financial  statements and accompanying notes.
Actual results could differ from those estimates.


Long-Lived Assets                                          
                                                                         
In March 1995,  the FASB  issued SFAS 121,  "Accounting  for the  Impairment  of
Long-Lived  Assets and for Long-Lived  Assets to Be Disposed Of," which requires
impairment  losses to be recorded on long-lived  assets used in operations  when
indicators of impairment are present and the  undiscounted  cash flows estimated
to be generated by those assets are less than the assets' carrying amount.  SFAS
121 also addresses the accounting for long-lived  assets that are expected to be
disposed  of.  The  Company  adopted  SFAS 121  effective  January  1,  1996 and
determined that no impairment exists.
                                     

Reclassifications

Certain reclassifications have been made to prior years' financial statements to
conform to the current presentation.


2. Subsequent Event

In February 1998, the Company  entered into a preliminary  agreement to purchase
the stock of its licensee in the United Kingdom in exchange for the debt owed to
the Company. A formal agreement is pending and should be consummated in the near
future.









                                      F-11



                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


3. Research and Development Expenses

Research and  development  expenses of $286,000,  $289,000 and $294,000 in 1997,
1996 and 1995, respectively, were charged to selling, general and administrative
expenses as incurred.


4. Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses at December 31, 1997 and 1996,  consist of
the following:

                                              1997                1996
                                       ----------------------------------

Trade payables                            $1,432,901          $1,688,777
Distributors commissions                   1,326,579           1,064,023
Sales taxes                                  192,130             225,509
Payroll and payroll taxes                    173,689             391,905
Other                                        164,832             125,844
                                       ----------------------------------
                                          $3,290,131          $3,496,058
                                       ==================================

5. Short-Term Borrowings

In January 1996, the Company  obtained two separate lines of credit amounting to
$500,000 and  $800,000,  respectively.  Borrowings  under the  $500,000  line of
credit are due January 1998 and bear  interest,  payable  monthly,  at the prime
rate.  Borrowings  under the $800,000  line of credit are due February  2001 and
bear interest,  payable  monthly,  at the prime rate. A portion of the Company's
inventory and property,  plant and equipment with a net book value of $2,747,000
as of  December  31,  1997  are  pledged  as  security  under  the  terms of the
agreements.   The  agreements  include   restrictive   covenants,   including  a
requirement  that  the  Company  maintain  a  current  ratio of 1.5 to 1.0 and a
minimum net worth of  $5,500,000.  As of December 31,  1997,  the Company had no
borrowings against these lines of credit.







                                      F-12



                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


6. Long-Term Debt

Long-term debt at December 31, 1997 and 1996, consists of the following:



                                                                                           1997             1996
                                                                                   -------------------------------

                                                                                                 
Industrial revenue bonds payable in monthly installments  (including interest at
   85% of prime) not to exceed  $9,611,  commencing  August 1, 1991;  secured by
   land and building (net book value  $2,789,000 at December 31, 1997);  balance    
   due on March 1, 2005                                                              $    597,907      $   649,476
                                                                          


Note payable in monthly installments (including interest at prime and additional
   interest  at 15% of prime on the  balance of the  industrial  revenue  bonds)
   equal  to  $9,611  less  installment  applied  to  industrial  revenue  bond,
   commencing August 1, 1991; unsecured; balance due on March 1, 2005                     204,755          204,755
                                                                                          

Term loan payable in monthly installments of $19,550, including interest at 8.5%
   through April 2001;  secured by equipment  and  inventory  (net book value of
   $2,747,000 at December 31, 1997)                                                       662,133          830,705
                                                                              

Construction  loan  payable  in  interest  only  at  8.5%  through  March  1998.
   Thereafter payable in monthly  installments of $38,802 , with the balance due
   March 2001;  secured by land and building  (net book value of  $5,157,000  at                                 
   December 31, 1997)                                                                   3,958,514              --             
                                                                                   -------------------------------     
                                                                                        5,423,309        1,684,936         
Less current maturities                                                                  (313,789)        (220,068)        
                                                                                   -------------------------------   
                                                                                       $5,109,520       $1,464,868         
                                                                                   ===============================  

 






                                      F-13



                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


6. Long-Term Debt (continued)

Principal maturities of long-term debt at December 31, 1997 are as follows:

              1998                      $     313,789
              1999                            358,210
              2000                            391,508
              2001                          3,829,270
              2002                             83,393
              Thereafter                      447,139
                                        ------------- 
                                        $   5,423,309
                                        ============= 


7. Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per
share:




                                                                             Year ended December 31
                                                                       1997          1996           1995
                                                                   ----------------------------------------

                                                                                          
Numerator:
   Numerator for basic and diluted earnings per     
     share - net income                                            $ 2,028,988   $ 1,507,014   $    569,823
Denominator:
   Denominator for basic earnings per share -
     weighted average shares                                         9,600,000     9,854,000     10,280,000
   Effect of dilutive securities:
     Employee stock options and other warrants                         707,000       471,000         24,000                  
                                                                   ----------------------------------------
   Denominator for diluted earnings per share -
     adjusted weighted average shares                               10,307,000    10,325,000     10,304,000 
                                                                   ======================================== 
                                                                   

Basic earnings per share                                                $ 0.21        $ 0.15         $ 0.06
                                                                   ========================================
Diluted earnings per share                                              $ 0.20        $ 0.15         $ 0.06
                                                                   ======================================== 

 






                                      F-14



                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


8. Stock Options, Warrants, Treasury Stock and Repurchase Agreements

Stock Options

The Company had an incentive  stock option plan for key employees  which expired
in January 1995.  Accordingly,  no additional  options can be granted under this
plan as of that date.  At December  31,  1995,  options  for 189,200  shares and
250,800  shares  were  outstanding  at an option  price of $2.045  and $2.25 per
share,  respectively.  The  options are  exercisable  at various  dates  through
December 1999.

In May 1995,  the Company  adopted a stock  option plan which  provides  for the
grant of incentive  stock options and  nonqualified  stock options for employees
(including  officers)  and other  consultants  and  advisors to the  Company.  A
maximum of  1,100,000  shares can be  purchased at an option price not less than
the fair market value of the stock at the time the options are granted.

As the  result of the  Company's  10%  stock  dividend  in  February  1997,  all
outstanding  options  and  warrants  were  adjusted  to  reflect  for the  stock
dividend.

The Company has  elected to follow APB  Opinion  No. 25,  "Accounting  for Stock
Issued to Employees," (APB 25) and related interpretations in accounting for its
employee and nonemployee director stock options because, as discussed below, the
alternative fair value accounting  provided for under SFAS 123,  "Accounting for
Stock-Based Compensation," requires the use of option valuation models that were
not developed for use in valuing  employee stock options.  Under APB 25, because
the exercise  price of the Company's  employee and  nonemployee  director  stock
options equals the market price of the underlying stock on the date of grant, no
compensation expense is recognized.

Pro forma information regarding net income and earnings per share is required by
SFAS  123 and has  been  determined  as if the  Company  had  accounted  for its
employee  stock options under the fair value method of the  statement.  The fair
value for these options was estimated at the date of grant using a Black-Scholes
option pricing model with the following weighted average assumptions:  risk-free
interest  rates  ranging from 5.15% to 5.30% for 1995,  5.15% to 6.10% for 1996,
and 5.70% to 5.97% for 1997;  dividend yield of .50%;  volatility  factor of the
expected price of the Company's  stock of .658 for 1995 and 1996, .624 for 1997;
and a weighted average expected life of the options of 3.54 years.




                                      F-15



                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


8. Stock Options, Warrants, Treasury Stock and Repurchase Agreements (continued)

Stock Options (continued)

The Black-Scholes option valuation model was developed for use in estimating the
fair value of traded  options which have no vesting  restrictions  and are fully
transferable.  In addition,  option valuation models require the input of highly
subjective  assumptions  including the expected stock price volatility.  Because
the   Company's   employee  and   nonemployee   director   stock   options  have
characteristics significantly different from those of traded options and because
changes in the subjective input assumptions can materially affect the fair value
estimate,  in  management's  opinion,  the  existing  models do not  necessarily
provide  a  reliable  single  measure  of the  fair  value of its  employee  and
nonemployee director stock options.

For purposes of pro forma  disclosures,  the estimated fair value of the options
and warrants is amortized  to expense  over the vesting  period.  The effects of
applying the pro forma  disclosure  provisions  of SFAS 123 are not likely to be
representative  of the  effects on  reported  net income for future  years.  The
Company's pro forma information follows:

                                           1997           1996          1995
                                      ----------------------------------------- 

Pro forma net income                    $1,861,748     $1,385,941      $537,842

Pro forma earnings per share:
       Basic                                  $.19           $.14          $.05
       Diluted                                $.18           $.13          $.05






                                      F-16



                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


8. Stock Options, Warrants, Treasury Stock and Repurchase Agreements (continued)

Stock Options (continued)

A summary of the Company's stock option activity and related information for the
years ended December 31 follows:



                                    1997                        1996                        1995
                          ------------------------------------------------------------------------------------
                                          Weighted                    Weighted                    Weighted
                                            Avg.                        Avg.                        Avg.
                                          Exercise                    Exercise                    Exercise
                             Options        Price        Options        Price        Options        Price
                          ------------------------------------------------------------------------------------

                                                                                    
Outstanding beginning of 
  the year                 1,076,900        $1.841       883,850        $1.712        440,000       $2.162
Granted:
  Price = fair value         100,000         3.125       206,250         2.355        385,550        1.250
  Price > fair value             --            --            --            --          58,300        1.375
Exercised (1)                (11,000)        1.506       (10,450)        1.250            --           --
Forfeited                        --            --         (2,750)        1.250            --           --
                          -----------                 -----------                  -----------
Outstanding at
  end of year              1,165,900        $1.954     1,076,900        $1.841        883,850       $1.712
                          ===========                 ===========                  ===========

Exercisable at end of  
  year                       723,332           --        496,828           --         271,514           --
                          ===========                 ===========                  ===========





                             As of December 31, 1997

                            Options Outstanding                                      Options Exercisable
                    -------------------------------------                     ----------------------------------
Range of Exercise        Number         Weighted Avg.       Weighted Avg.         Number        Weighted Avg.
      Prices          Outstanding       Remaining Life      Exercise Price      Exercisable     Exercise Price
- ------------------- ----------------- ------------------- ------------------- ---------------- -----------------

                                                                                        
$1.25 - $2.00            482,900             2.95              $1.325             274,999           $1.331
$2.01 - $2.875           583,000             2.31               2.273             348,333            2.233
$3.125                   100,000             4.96               3.125             100,000            3.125
                      ----------                                               -----------   

$1.25 - $3.125         1,165,900             2.80              $1.954             723,332           $2.014
                      ===========                                              ===========   





(1) Shares  issued were less than  options  exercised  due to cashless  exercise
provision.






                                      F-17



                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements



8. Stock Options, Warrants, Treasury Stock and Repurchase Agreements (continued)

Warrants

In 1995,  the Company,  as part of a consulting  agreement,  issued  warrants to
purchase  3,364 shares of common stock.  The exercise  prices of these  warrants
ranged from $.045 per share to $1.932 per share and had a term of two years.  In
1996, as part of this same  agreement,  the Company issued  warrants to purchase
38,035  shares with the same range of exercise  prices and terms of the warrants
issued in the  previous  year.  In 1997,  as a renewal  of this  agreement,  the
Company  issued  warrants to purchase 9,600 shares at an exercise price of $6.25
per share with a term of two years.

In July 1996,  as part of another  consulting  agreement,  the Company  issued a
warrant to  purchase  101,948  shares of common  stock at an  exercise  price of
$4.182 per share. This warrant has a term of three years.

A summary of the  Company's  warrant  activity and related  information  for the
years ended December 31 follows:



                                     1997                        1996                        1995
                          ------------------------------------------------------------------------------------
                                          Weighted                    Weighted                    Weighted
                                            Avg.                        Avg.                        Avg.
                                          Exercise                    Exercise                    Exercise
                            Warrants        Price       Warrants        Price       Warrants        Price
                          ------------------------------------------------------------------------------------

                                                                                  
Outstanding beginning of  
  the year                   143,347       $3.430         3,364        $1.496            --        $  --
Granted:
  Price < fair value             --            --         6,989         0.045            777        0.045
  Price = fair value           9,600        6.250        31,046         1.932          2,587        1.932
  Price > fair value             --            --       101,948         4.182            --           --
Exercised (1)                (41,400)       1.578           --            --             --           --
Forfeited                        --            --           --            --             --           --
                          -----------                -----------                  ----------- 
Outstanding at  
  end of year                111,547       $4.360       143,347        $3.430          3,364       $1.496
                          ===========                ===========                  =========== 

Exercisable at end of
  year                       111,547          --        143,347           --           3,364          --
                          ===========                ===========                  =========== 


(1) Shares  issued were less than warrants  exercised  due to cashless  exercise
provision.







                                      F-18



                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements



8. Stock Options, Warrants, Treasury Stock and Repurchase Agreements (continued)

Warrants (continued)



                             As of December 31, 1997

                           Warrants Outstanding                                   Warrants Exercisable
                    ------------------------------------                   ------------------------------------
Range of Exercise       Number         Weighted Avg.       Weighted Avg.         Number         Weighted Avg.
      Prices          Outstanding      Remaining Life     Exercise Price      Exercisable      Exercise Price
- ------------------- ---------------- ------------------- ------------------ ----------------- ------------------

                                                                                       
$4.182                   101,947            1.496             $4.182           101,947             $4.182
$6.250                     9,600            1.456              6.250             9,600              6.250
                        ---------                                           ----------- 

$4.182 - $6.25           111,547            1.492             $4.360           111,547             $4.360
                        =========                                           =========== 


Treasury Stock and Repurchase Agreements

In October 1992, the Company  entered into a stock  repurchase  agreement with a
former  officer/director  of  the  Company.  Under  the  agreement,   which  was
retroactive to July 1992,  the Company was obligated to purchase  259,686 of the
individual's  shares of Company common stock. The mandatory purchase occurred in
six  quarterly  installments  of  43,281  shares  beginning  in  July  1992  and
concluding in December  1993. As of December 31, 1993,  the Company had redeemed
all 259,686 shares required by the agreement for $657,683.

Under  the same  agreement,  the  Company  also had the  option to  purchase  an
additional 432,814 of the individual's shares on the basis of 43,281 shares each
quarter beginning in January 1995 and concluding in April 1996. Through December
31, 1996, the Company had exercised all options under the agreement and redeemed
an additional 432,814 shares for $870,218. As of December 31, 1997, all treasury
shares had been retired.

In May 1997,  a former  officer/director  filed a demand  for  arbitration  with
respect to the stock purchase agreement and consulting agreement entered into in
October   1992.   The   demand   claims    damages    resulting   from   alleged
misrepresentations  made by the Company regarding these agreements.  The Company
believes the claim is without merit and intends to vigorously  defend itself. At
this time, the outcome of this matter is uncertain and a range of loss cannot be
reasonably estimated.  However,  management believes that the final outcome will
not have a material adverse effect on the financial position of the Company.




                                      F-19



                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements



9. Leases

The Company  leases  certain  manufacturing,  storage and office  facilities and
certain equipment and automobiles.  These leases have varying terms, and certain
leases have renewal  and/or  purchase  options.  Future  minimum  payments under
noncancelable  leases  with  initial  or  remaining  terms in excess of one year
consist of the following at December 31, 1997:

                                                    Capital    Operating Leases
                                                    Leases
                                                  ----------------------------- 

   1998                                              $50,443           $239,442
   1999                                               35,527            216,164
   2000                                                6,040            136,736
   2001                                                    -             83,256
   2002                                                    -             70,004
   Thereafter                                              -                 -
                                                  ----------------------------- 
   Total minimum lease payments                       92,010           $745,602
                                                                =============== 
   Less amount representing interest                   8,570
                                                  ----------- 
   Present value of minimum lease payments
     (including current portion of $44,335)          $83,440
                                                  =========== 

Machinery,  office and computer equipment at December 31, 1997 and 1996, include
approximately  $246,333 and  $410,662 of  equipment  under leases that have been
capitalized.  Accumulated  depreciation  and  amortization  for  such  equipment
approximated $154,978 and $344,539 at December 31, 1997 and 1996, respectively.

Rent expense for all operating  leases was  $311,554,  $289,979 and $167,985 for
the years ended December 31, 1997, 1996 and 1995, respectively.

10. License Agreement

The Company has a license  agreement  with the  individual who developed many of
the Company's  products.  This agreement provides the Company with the exclusive
worldwide  license to manufacture and sell all products  created by the licensor
and requires monthly royalty payments of 5 percent of net sales,  with a minimum
payment of $10,000 and a maximum  payment of $22,000.  The agreement  terminates
the earlier of December 2001 or on the death of licensor.  The amount of expense
under this agreement was $264,000 for each of the years ended December 31, 1997,
1996 and 1995, respectively.




                                      F-20





                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


11. Income Taxes

The components of income before income taxes are as follows:

                                           Year ended December 31
                                1997                1996               1995
                         -----------------------------------------------------

Domestic                 $   3,625,708       $   2,710,323           $646,978
Foreign                       (211,720)           (253,309)           109,845
                         -----------------------------------------------------
                         $   3,413,988       $   2,457,014           $756,823
                         =====================================================

The components of the provision for income taxes are as follows:

                                         Year ended December 31
                                1997                1996               1995
                         -----------------------------------------------------
Current:
   Federal               $    1,239,000        $    758,000       $    31,000
   Foreign                       38,000              88,000           124,000
   State                        134,000             108,000            18,000
                         -----------------------------------------------------
Total current                 1,411,000             954,000           173,000

Deferred:
   Federal                      (24,000)             (3,000)           (1,000)
   Foreign                            -              (1,000)           15,000
   State                         (2,000)                  -                 -
                         -----------------------------------------------------
Total deferred                  (26,000)             (4,000)           14,000
                         -----------------------------------------------------

                         $    1,385,000        $    950,000       $   187,000
                         =====================================================




                                      F-21




                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


11. Income Taxes (continued)

The  provision  for income  taxes is  different  from the  amounts  computed  by
applying the United States federal statutory income tax rate of 34 percent.  The
reasons for these differences are as follows:

                                                  Year ended December 31
                                             1997          1996         1995
                                       ---------------------------------------- 

Income taxes at statutory rate          $ 1,161,000    $ 835,000    $  257,000
Difference between financial 
   statement and federal
   income tax recognition
   of foreign losses                            --           --      (101,000)
Differences between U.S. 
   and foreign tax rates on
   foreign income                            27,000       12,000          --
State income taxes, 
   net of federal benefit                    88,000       71,000       12,000
Provision for IRS audit settlement           75,000          --           --
Other                                        34,000       32,000       19,000
                                       ---------------------------------------
                                        $ 1,385,000    $ 950,000    $ 187,000
                                       =======================================

Effective December 31, 1995, the Company hybridized its Canadian  subsidiary for
federal income tax purposes.  During 1995, the Company  recognized an income tax
benefit  in  excess of the  foreign  loss  recognized  for  financial  statement
purposes as a result of this hybridization.

The  components  of the  deferred  tax asset and the related tax effects of each
temporary difference at December 31, 1997 and 1996, are as follows:

                                           1997            1996
                                       ---------------------------
Deferred tax asset:
   Product refund reserve               $ 18,000        $  29,000
   Obsolescence reserve                   40,000              --
   Bad debt reserve                        3,000            6,000
   Miscellaneous accrued expenses         29,065           30,000
                                       ---------------------------
                                        $ 90,065        $  65,000
                                       ===========================

Federal income taxes have not been provided on the undistributed earnings of the
Company's  Australian and New Zealand subsidiaries since the Company has foreign
tax credits available to offset any related federal income taxes.





                                      F-22



                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements



11. Income Taxes (continued)

The Internal  Revenue Service (IRS)  examinations of the Company's U.S.  federal
income tax returns for fiscal  years 1992  through  1994  resulted in a proposed
assessment  against the Company.  In early 1998,  this  examination was resolved
with no material adverse effect on the Company's  financial  position or results
of operation.

12. Employee Benefit Plans

In 1995,  the Company  established a 401(k)  employee  savings plan which covers
substantially all employees. During 1995 and 1996, employees could contribute up
to 5 percent  of their  gross  income to the plan,  and the  Company  matched 50
percent of the employee's  contribution.  Company  contributions totaled $23,000
and $11,000 in 1996 and 1995, respectively. For 1997, employees could contribute
up to 7.5 percent of their gross income to the plan and the Company  matched 100
percent of the employee's  contribution.  Company contributions under the 401(k)
plan totaled $115,000 in 1997. In 1997, the Company merged a pre-existing profit
sharing plan into the 401(k) plan. Company  contributions totaled $0 and $35,000
in 1996 and 1995,  respectively for  discretionary  contributions for the former
profit sharing plan.

13. Incentive Compensation Plans

Effective January 1, 1994, the Company adopted an annual incentive  compensation
plan   and   a   long-term   incentive   plan.   These   plans   include   three
officers/directors  and are effective  until  termination  of their  employment.
Participants in the plan are entitled to receive  additional  compensation based
on  the  attainment  of  defined  annual  and  long-term  performance  measures.
Incentive  compensation  under each of the plans cannot exceed the participant's
base salary rate. The base salary rates and the performance  measures  specified
by both plans are established annually by the Board of Directors.

The Company paid approximately $240,000, $525,000 and $0 in 1997, 1996 and 1995,
respectively, under its incentive compensation plans.




                                      F-23




                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


14. Employment Agreements

In November  1992, the Company  entered into a services  agreement with a former
officer  for a term  retroactively  commencing  in July  1992  and  expiring  in
December 1999. The agreement provides for a minimum monthly salary and incentive
compensation  based upon the profits (defined as "income before income taxes and
incentive compensation  expense") of the foreign subsidiaries.  The Company paid
approximately   $50,000,   $50,000  and   $120,000  in  1997,   1996  and  1995,
respectively, under the terms of the agreement.

Effective  January 1, 1994, the Company entered into employment  agreements with
three  officers/directors  and  in  June,  1997,  entered  into  new  employment
agreements  with  two of  these officers/directors.  The  employment  agreements
provide for base salary rates  established  annually by the Board of  Directors.
The Company paid base salaries of $960,000,  $960,000 and $768,750 in 1997, 1996
and 1995, respectively, under the terms of the agreements.

15. Related Party Transactions

An  officer/director  of the Company is a principal in a law firm which provides
legal services to the Company.  During the years ended  December 31, 1997,  1996
and 1995,  the Company  incurred  fees to the  officer/director  and his firm of
approximately $332,000, $231,000 and $305,000, respectively.

Accounts   and   notes    receivable    include    accounts    receivable   from
officers/directors of $4,633, $4,633 and $219,082 at December 31, 1997, 1996 and
1995, respectively.

During  1996,  the Company  paid  $121,000  for goods and  services to a company
wholly  owned by three  officers/directors  and one  director  of the company in
connection with promotional activities.









                                      F-24




                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


16. Consulting Agreements

In October 1992, the Company  entered into a consulting  agreement with a former
officer/director  of the  Company.  Under  the  agreement,  which  retroactively
commenced  in July 1992 and  expired  in June 1996,  (1) the  officer/director's
employment  agreement was  terminated,  (2) the individual  provided  consulting
services  and advice to the  Company for the term of the  agreement  and (3) the
individual  agreed not to compete  with the Company  anywhere  within the United
States from July 1992 through December 1995. The  individual's  compensation for
providing  consulting  services and not competing was approximately  $134,000 at
the time the  agreement  was  executed,  plus  $4,500  per month  from July 1992
through  December  1992  and 1  percent  of the  suggested  retail  value of the
Company's  United  States sales from July 1992 through June 1996.  Total expense
under  this  agreement  approximated  $203,000  and  $342,000  in 1996 and 1995,
respectively.

In  conjunction  with an  acquisition,  the Company  entered  into a  consulting
agreement  with  a  partnership  consisting  of  three  individuals.  Under  the
agreement,  which  commenced  in March 1992 and  expires in February  2002,  the
Company will pay annual consulting fees to the partnership equal to 2 percent of
the new  company's  retail  sales  (defined  as "the gross  sales  amount of all
products  sold by the Company in  Australia  and New Zealand  determined  by the
suggested  retail  price")  up  to   approximately   $A10,000,000  in  1992  and
$A12,000,000  in all  subsequent  years  during the term and 3 percent of retail
sales that exceed those figures. Total expense under this agreement approximated
$96,000, $133,000 and $185,000 in 1997, 1996 and 1995, respectively.

17. Segment Information

In 1995,  substantially all of the Company's assets, sales and operating results
were employed in or derived from the manufacture and direct sale of nutritional,
diet and skin care  products to a sales force of  independent  distributors  who
sell  products  directly to customers  (network  marketing).  In late 1995,  the
Company  began  performing   contract  processing  and  packaging  services  for
unrelated customers.








                                      F-25




                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements




17. Segment Information (continued)

Segment data provided is for the 1997 and 1996 fiscal years only, as the Company
began  contract  manufacturing  in late 1995 and the  results  for 1995 were not
material.

                                                  1997                1996
                                             --------------------------------

Net sales
  Network marketing                          $ 45,311,467        $ 37,419,875
  Contract manufacturing                        1,524,803           3,310,118
                                             --------------------------------
                                             $ 46,836,270        $ 40,729,993
                                             ================================
                                                                
Operating income
  Network marketing                          $  5,116,625        $  4,055,671
  Contract manufacturing                          (16,140)           (200,532)
  Corporate expenses                           (1,589,374)         (1,333,077)
                                             --------------------------------
  Operating income                              3,511,111           2,522,062
  Nonoperating income (net)                       113,145             147,771
  Interest expense                               (210,268)           (212,819)
  Income tax expense                           (1,385,000)           (950,000)
                                             --------------------------------
  Net income                                 $  2,028,988        $  1,507,014
                                             ================================
                                                               
Identifiable assets
  Network marketing                          $ 12,740,414        $  7,772,109
  Contract manufacturing                          803,108           1,420,786
  Corporate                                     2,426,426           2,208,770
                                             --------------------------------
                                             $ 15,969,948        $ 11,401,665
                                             ================================
                                                                 
Depreciation and amortization  
  Network marketing                          $    457,194        $    452,483
  Contract manufacturing                          150,087             176,674
                                             --------------------------------
                                             $    607,281        $    629,157
                                             ================================
                                                                
Capital expenditures
  Network marketing                          $  5,012,770        $    384,818 
  Contract manufacturing                           41,956             380,568
                                             --------------------------------
                                             $  5,054,726        $    765,386
                                             ================================
                                                                


Operating profit is total revenue less operating  expenses,  excluding interest,
corporate  expenses  and income tax  expense.  Identifiable  assets by  business
segment  include both assets directly  identified  with those  operations and an
allocable share of jointly used assets.  Corporate  assets consist  primarily of
cash and nonoperating accounts receivable.





                                      F-26



                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


18. Geographic Segment Data

Financial information, summarized by geographic area, is as follows:

United States inter-area transfers represent shipments of nutritional,  diet and
skin care products to the foreign subsidiaries.



                        United                       New 
                        States      Australia      Zealand      Canada (1)   Mexico (2)  Eliminations   Consolidated
                     ------------------------------------------------------------------------------------------------
                                                                                       
Year ended
 December 31, 1997
Net sales:
 Unaffiliated       
  customers           $41,718,773   $2,560,714      $888,710    $1,338,425   $329,648     $     --      $46,836,270
 Inter-area                                      
  transfers               751,555       48,570          --             --         --       (800,125)           --
                     -----------------------------------------------------------------------------------------------
Total                 $42,470,328   $2,609,284      $888,710    $1,338,425   $329,648     $(800,125)    $46,836,270
                     ===============================================================================================

Net income (loss)     $ 2,177,300   $   49,910      $ (1,989)   $ (109,750)  $(86,483)    $     --      $ 2,028,988
                     ===============================================================================================

Identifiable assets   $13,202,451   $1,488,667      $534,465     $ 467,467   $276,898     $     --      $15,969,948
                     ===============================================================================================
<FN>

(1)  The Canadian  subsidiary's  loss from operations of $166,750 is offset by a
     United Stated federal tax benefit of  approximately  $57,000 related to the
     Canadian subsidiary's losses.

(2)  The Mexican  subsidiary's  loss from  operations of $130,483 is offset by a
     United States federal tax benefit of  approximately  $44,000 related to the
     Mexican subsidiary's losses.

</FN>




                        United                       New 
                        States      Australia      Zealand      Canada (3)   Mexico (4)  Eliminations   Consolidated
                     ------------------------------------------------------------------------------------------------

                                                                                      
Year ended
 December 31, 1996
Net sales:
 Unaffiliated 
 customers            $34,408,349   $3,550,213     $1,172,743   $1,246,624   $ 352,063    $     --      $40,729,992
 Inter-area   
 transfers                910,402       83,307            --           --          --      (993,709)            --
                     ----------------------------------------------------------------------------------------------- 
Total                 $35,318,751   $3,663,520     $1,172,743   $1,246,624    $352,063    $(993,709)    $40,729,992
                     =============================================================================================== 
                   
Net income (loss)     $ 1,685,771   $  115,033     $   19,717   $ (164,066)   $(149,441)  $     --      $ 1,507,014
                     =============================================================================================== 

Identifiable assets   $ 8,340,211   $1,472,565     $  668,501   $  692,905    $ 227,483   $     --      $11,401,665
                     =============================================================================================== 
<FN>

(3)  Canadian  subsidiary's  loss from  operations  of  $249,066  is offset by a
     United Stated federal tax benefit of  approximately  $85,000 related to the
     Canadian subsidiary's losses.

(4)  The Mexican  subsidiary's  loss from  operations of $226,441 is offset by a
     United States federal tax benefit of  approximately  $77,000 related to the
     Mexican subsidiary's losses.
</FN>


                                      F-27




                   Reliv' International, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements



18. Geographic Segment Data (continued)



                        United                      New 
                        States     Australia      Zealand     Canada (5)   Mexico (6)  Eliminations   Consolidated
                     ----------------------------------------------------------------------------------------------

                                                                                     
Year ended
 December 31, 1995
Net sales:
 Unaffiliated 
 customers           $22,223,817  $4,311,351     $1,448,785   $494,167     $ 435,753    $     --       $28,913,873
 Inter-area   
 transfers                92,976     197,620            --         --            --      (290,596)             -- 
                     ----------------------------------------------------------------------------------------------
Total                $22,316,793  $4,508,971     $1,448,785   $494,167     $ 435,753    $(290,596)     $28,913,873
                     ==============================================================================================
            
Net income (loss)    $  430,262   $  232,536     $   38,153   $   (185)    $(130,943)   $      --      $   569,823
                     ============================================================================================== 
                    
Identifiable assets  $  7,893,171 $1,473,242     $   433,683  $342,990     $ 133,148    $      --      $10,276,234
                     ============================================================================================== 
<FN>

(5)  The Canadian  subsidiary's  loss from operations of $101,185 is offset by a
     United States federal tax benefit of approximately  $101,000 related to the
     Canadian subsidiary's losses.

(6)  The Mexican  subsidiary's  loss from  operations of $198,943 is offset by a
     United States federal tax benefit of  approximately  $68,000 related to the
     Mexican subsidiary's losses.
</FN>




19. Quarterly Financial Data (Unaudited)

                               First       Second         Third        Fourth
                           ---------------------------------------------------- 
                                    (In thousands, except per share amounts)

                1997
Net sales                   $  12,670    $  11,771     $  11,480     $  10,915
Cost of products sold       $   2,532    $   2,337     $   2,521     $   2,015
Net income                  $     819    $     595     $     282     $     333
Earnings per share (1):
   Basic                    $     .09    $     .06     $     .03     $     .03
   Diluted                  $     .08    $     .06     $     .03     $     .03

                1996
Net sales                   $   9,304    $   9,448     $   9,934     $  12,044
Cost of products sold       $   2,568    $   2,415     $   2,348     $   2,862
Net income                  $     278    $     302     $     338     $     589
Earnings per share (1):
   Basic                    $     .03    $    .03      $     .03     $     .06
   Diluted                  $     .03    $    .03      $     .03     $     .06


(1)  Per share data for 1996  reflects the pro forma effect of the  Company's 10
     percent  stock  dividend  declared on January 31, 1997 and  distributed  on
     February 28, 1997.




                                      F-28


                                                                           
                   Reliv' International, Inc. and Subsidiaries

                 Schedule II - Valuation and Qualifying Accounts

              For the years ended December 31, 1997, 1996 and 1995




            Column A                  Column B       Column C      Column D       Column E     Column F
- ----------------------------------------------------------------------------------------------------------
                                                           Additions
                                                   ------------------------- 
                                      Balance at    Charged to   Charged to                    Balance at 
                                      beginning     costs and       other        Deductions        end 
        Classification                 of year      expenses      accounts        describe      of year            
- ----------------------------------------------------------------------------------------------------------

Year ended December 31, 1997
- ----------------------------                                                                      
                                                                                     
  Deducted from asset accounts:
     Allowance for doubtful           
       accounts                      $  13,000       $    --       $    --      $   5,400(1)    $   7,600 
     Reserve for obsolete                                                                               
       inventory                       125,000            --            --         16,000(2)      109,000  
  Supporting liability                                                                               
       accounts:                                                                                        
     Reserve for refunds                78,800         186,000          --        214,800(3)       50,000 
                                     ---------------------------------------------------------------------

Year ended December 31, 1996                                                                                             
- ----------------------------                                                                                             
                                                                                                                         
  Deducted from asset accounts:                                                                                         
     Allowance for doubtful                                                                                              
       accounts                      $   7,000       $  78,700      $    --     $  72,700(1)   $  13,000               
     Reserve for obsolete                                                                     
       inventory                           --          125,000           --            --        125,000 
  Supporting liability 
       accounts:                                                                                         
     Reserve for refunds                78,800          92,000           --        92,000(3)      78,800         
                                                                                                                         
                                 ------------------------------------------------------------------------- 

Year ended December 31, 1995                                                                                
- ----------------------------                                                                   
  Deducted from asset accounts:                                                                                         
     Allowance for doubtful                                                                                              
       accounts                      $  29,000                      $    --         22,000(1)      7,000         
  Supporting liability                                                                                                     
       accounts:                                                                                                         
     Reserve for refunds                54,800         195,000           --        171,000(3)     78,800       
                                                                                                                     
                                 -------------------------------------------------------------------------- 

<FN>                                
(1)   Uncollectible accounts written off, net of recoveries.
(2)   Disposal of obsolete inventory.
(3)   Amounts refunded, net of salable amounts returned.
</FN>





                                      F-29